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General introduction 
Pathways and control of steroid biosynthesis 
The hormones secreted by the testis, the androgens, 
maintain and control the development of the male accessory 
reproductive organs and secondary sexual characteristics. 
There are two principal androgens, testos,terone and andros-
tenedione and they are synthesized in the interstitial tis-
sue of the testis. 
It is generally accepted that these steroids are deri-
5 
ved from cholesterol and are formed along the 6 ,3s-hydroxy-
steroid pathway and the ~ 4 ,3-oxosteroid pathway1 ' 2 ' 3 
(fig. 1). The first steps in steroidogenesis ar,e basically 
the same in the mammalian testis, ovary and adrenal gland. 
Androstenedione and testosterone are precursors for ovarian 
oestrogen biosynthesis, while progesterone and !?a-hydroxy-
progesterone are utilized in the formation of cortico-
steroids in the adrenal cortex. 
It has been shown that in the hog adrenal gland the 
cholesterol side-chain cleaving enzyme is localized in the 
inner membrane of the mitochondria 4 . A major portion of the 
pregnenolone is probably formed by an enzyme-mediated attack 
of oxygen on cholesterol, resulting in the formation of 
20a,22R-dihydroxycholesterol, which is subsequently oxida-
5 tively cleaved to pregnenolone Pregnenolone leaves the 
mitochondria and is converted to testosterone by enzymes, 
localized on the smooth-surfaced endoplasmatic reticulum6 
Considerable information is available on the properties of 
the 6 5 ,36-hydroxysteroid dehydrogenase and its mechanism 
of action~ it is a single, NAD+-dependent enzyme oxidizing 
all four 6 5 ,3s-hydroxysteroids 1 ' 7 . In contrast, the presence 
of several substrate-specific 6 5 ,6 4-isomerases has been 
demonstrated in bovine adrenal gland preparations 8 ' 9 . The 
cholesterol side-chain cleaving enzyme and the c 17 , 20-lyase 
show the same requirements as the steroid hydroxylation 
reactions i.e. NADPH, oxygen and the presence of cytochrome 
15 
P450
6
,
10 The !?a-dehydrogenation is reversible and NAD(H)/ 
NAD(P)H-dependent. The presence of steroid sulphokinase and 
steroid sulphatase activities and of enzymes which metabo-
lize steroid hormones is described 
the rat testis the 64 ,3-oxosteroid 
later in this thesis. In 
pathway 
route for testosterone biosynthesis, while 
are involved in the testes of man, dog and 
is the preferred 
both pathways 
rabbit 1 ' 2 ' 3 . 
Testosterone production in the testis is regulated by 
an interplay with the hypophysial hormone LH. Administra-
tion of LH (or HCG) leads to an increased testosterone pro-
duction through the stimulation of the conversion of choles-
terol to pregnenolone which is the rate-limiting step in 
steroidogenesis. Androgens in turn regulate LH secretion 
through the negative feedback effect of testosterone on the 
hypothalamus and hypophysis. Decreased levels of circulating 
androgens result in an increased LH secretion by the hypo-
physis11. The biochemical mechanism through which LH exerts 
cholesterol side-
chain cleaving 
enzyme 
11-':3 p-hydroxysteroid 
pathway 
chol estero I 
1 
tJ. ~3-oxosteroid 
pathway 
pregnene] one progesterone 
17 c:l-hydroxylase---- -+ ~ 
17 Ci -hydroxypregnenol one _____.... 17 d -hydroxyprogesterone 
C -lyase-------,j, ~ ::.~;;y;;~;~- --- ~·~ldtepiandrostecone andlro~~tenedione 
drogenase ! 
5-androstene-3 ~, 17 ~-diol----+testosterone 
3 ~ -hydroxysteroid 
dehydrogenase 
and 6. 5, !J.4-isomerase 
Fig. 1 Pathways and enzymes involved in testosterone 
biosynthesis 
16 
its effect is largely unknown. In interstitial tissue of 
rat testis LH stimulates the formation of 3' ,5'-cAMP and 
testosterone and the increase in 3' ,5'-cAMP production 
. 12 13 
occurs before the increase in testosterone product~on ' 
A long term effect of LH in testis is to increase the acti-
vities of 6 5 ,3s-hydroxysteroid dehydrogenase, !?a-hydroxy-
lase and c 17 , 20-lyase
1
'
2 
Another possible control mechanism in regulating tes-
tosterone production is inhibition by steroids-at the cellu-
lar level. It is known that several steroids can inhibit 
the in vitro activity of enzymes required for steroid bio-
synthesis. In rat testis the c 17 , 20-lyase can be inhibited 
by 17a,20a-dihydroxy-4-pregnen-3-one, a metabolite of l?a-
14 hydroxyprogesterone 
The first part of this thesis describes an investiga-
tion in which the role of 17a,20a-dihydroxy-4-pregnen-3-one 
in the in vivo testosterone production is evaluated. 
The second part of this thesis deals with.the role of 
65 ,3S-hydroxysteroids as precursors and the relative impor-
tance of alternative pathways. The significance of the 
b5 ,3s-hydroxysteroid pathway and androstenediol in testos-
terone biosynthesis in rabbit testis was measured. In addi-
tion, the existence of precursors of dehydroepiandrosterone 
and androstenediol other than 17a-hydroxypregnenolone was 
investigated. 
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19 
1.1 Inhibition of steroid hormone biosynthesis 
1.1.1 Introduction 
Under in vitro conditions a large number of steroids 
can inhibit the enzymes involved in the biosynthesis of 
steroid hormones. Such steroid inhibitors can be found for 
almost every step in steroid hormone biosynthesis, possibly 
as a consequence of the basic structural properties which 
steroids have in common. Some of these inhibitors are natu-
rally occurring steroids and therefore the presence of a 
control of steroid hormone biosynthesis at the cellular 
level is often postulated. 
The occurrence of inhibition of steroid biosynthesis 
by steroids under in vivo conditions is difficult to esta-
blish. The description of inhibition has been restricted 
thusfar to observations of decreased conversions in vitro. 
Enzyme kinetics and the characteristics of inhibition have 
been studied in only a few cases and this has resulted in 
information on Km- and Ki-values, which is necessary for 
understanding the significance of inhibition as a regula-
ting factor. Constants were determined for the inhibition 
of c 17 , 20-lyase by 17a,20a-dihydroxy-4-pregnen-3-one
1
'
2 
and 
for the inhibition of ~ 5 ,3s-hydroxysteroid dehydrogenase 
by 7a-hydroxy-androstenedione 3as well as the inhibition of 
"d lf b . "d 4 - 8 stero~ su atase y varlous sterol s 
The best impression about the physiological signifi-
cance of such inhibitors may be derived from enzyme kinetic 
studies combined with information on the availability of a 
potential inhibitor at the site of steroid biosynthesis. On 
the basis of such data, Wiener and Allen9 ' 10 have proposed 
that inhibition of the 20a-hydroxysteroid dehydrogenase by 
oestrogens is part of the control mechanism in placental 
steroid biosynthesis of 20a-dihydroprogesterone. Jensen 
20 
et al.ll,l 2 used similar arguments when discussing the ef-
fect of dehydroepiandrosterone on the c 17 , 20-lyase activity 
in the human adrenal gland. 
The lack of information on endogenous tissue levels 
and the cellular localization of potential inhibitors ham-
per the evaluation of the inhibitor for the in vivo situa-
tion. Some authors have described effects of steroids which 
are present in relatively low or unknown concentrations, or 
which are not present at all at the site of s~eroid bio-
synthesis. This includes the inhibitory effects reported 
for 20a(and s)-dihydroprogesterone 1 ' 13 , oestradiol14 and 
deoxycorticosterone in the rat testis, and 11-deoxycortisol 
15-18 
and cortisol in the rat adrenal gland . Some of the in-
vestigated inhibitors are, however, formed at their presu-
med cellular site of action. For instance, the effect of 
corticosterone on mitochondrial NADH-oxidase may very well 
be of importance for the rate of liS-hydroxylation in the 
rat adrenal, because low concentrations (10 ~M) are required 
for inhibition19 and because the concentration in adrenal 
mitochondria is probably higher than at any other (sub)cel-
lular site in the rat. 
A detailed description of inhibition of steroid bio-
synthesis by steroids is given in paragraph 1.1.3. 
1.1.2 Scope of this investigation 
Most of the studies on the inhibition of steroid bio-
synthesis by steroids have been carried out in vitro. There 
have been few attempts to test the significance of in vitro 
results under in vivo conditions. It was decided therefore 
to investigate one potentially important inhibitor of ste-
roid biosynthesis, 17a,20a-dihydroxy-4-pregnen-3-one and 
its effect on testis c 17 20 -lyase under in vivo conditions. 
Inano and co-worker~l,2 have suggested that 20a-hydro-
xysteroid dehydrogenase might regulate testosterone biosyn-
21 
TH3 
~ r6~~H 
a-<JJ 
17 a -hydroxyprogesterone 
20 0.-hydroxysteroid 
dehydrogenase 
/ 
NADPH 
----
• 
/ 
/ 
/ 
170.,20 a-dihydroxy-
4-pregnen-3-one 
C 17, 20-lya•e~ 
NADPH,02 
<}----
0 
II 
andco.tenedione "ron 
0 
NADPH ----4 
-1 OH 
INHIBITION? 
testosterone 
o4dr from: Inane et al. (1967) Biochim. Biophys.Acta 137 540-548 
Fig. 1, A hypothetical mechanism for regulation of c
17 20
-lyase activity and 
androgen biosynthesis, 
thesis in the rat testis (fig. 1), This is a cytoplasrnatic 
enzyme which converts 17a-hydroxyprogesterone to 17a,20a-
dihydroxy-4-pregnen-3-one. The substrate specificity of the 
testicular enzyme differs from that of the 20a-hydroxyste-
roid dehydrogenases from the ovary, adrenal, placenta and 
liver, since progesterone is a poor substrate. The product 
17at20a-dihydroxy-4-pregnen-3-one was shown to 
biter of the c 17120-lyase. The Km-value of this 
17a-hydroxyprogesterone was 1.8 ~M 1 whereas the 
be an inhi-
enzyme for 
K.-value 
2 
for 17a,20a-dihydroxy-4-pregnen-3-one was 9 ~M. Competition 
of the 20a-hydroxysteroid dehydrogenase with the cl7t20-
22 
lyase for the substrate 17~-hydroxyprogesterone may also 
result in a decreased androgen production. 17a,20a-Dihydro-
xy-4-pregnen-3-one itself is not converted to androstene-
dione and testosterone. It is noteworthy that human testis 
can form 17a,20a-dihydroxy-4-pregnen-3-one from pregnenolo-
ne and 17a-hydroxypregnenolone 20 , 21 although in human tes-
tis the 6 5 ,3s-hydroxysteroid pathway is of more importance 
than the 6 4 ,3-oxosteroid pathway. 
All experiments that have been reported ~n the litera-
ture were carried out with subcellular fractions of total 
testis tissue, and information on either the endogenous 
levels of inhibitor, or on the intercellular localization 
of the 20a-hydroxysteroid dehydrogenase was not available. 
Therefore, four different types of experiments were carried 
out: 
1. The metabolism of radioactively labelled progesterone 
and 17a-hydroxyprogesterone and the formation of 17a, 
20a-dihydroxy-4-pregnen-3-one were studied in prepara-
tions of rat and rabbit testis. 
2. The effect of potential inhibitors on the c 17 , 20-lyase 
activity was investigated in in vitro incubation experi-
ments and during rabbit testis perfusions. 
3. A method for the estimation of 17a,20a-dihydroxy-4-
pregnen-3-one was developed and it was used to measure 
the endogenous levels of the 17a,20a-dihydroxy-4-pregnen-
3-one in testis and testicular venous blood. 
4. The localization of 20a-hydroxysteroid dehydrogenase was 
studied using isolated interstitial tissue and seminife-
rous tubules from dissected rat testis. 
Selective inhibition of c 17 , 20-lyase activity would 
depress testosterone biosynthesis without interfering with 
the biosynthesis of corticosteroids. This control of andro-
gen production might be of potential interest in the treat-
ment of benign prostatic hypertrophy, hirsutism and andro-
gen-dependent tumors. Therefore, the effect of a new syn-
thetic inhibitor of c 17 , 20-lyase, the l7B-ureido-1,4-andros-
tanedien-3-one22, was characterized. 
23 
1.1.3 A review 
The enzymes involved in steroidogenesis and their ste-
roid inhibitors are listed in table 1 at the end of this 
paragraph. This review is limited to the description of the 
direct effects of steroids on steroid biosynthesis and does 
not include observations which deal with indirect influences 
on steroid biosynthesis via feedback inhibition of gonado-
trophins or ACTH secretion by the hypophysis. 
Inhibition of cholesterol biosynthesis 
The results of Haksar et al. 23 ' 24 indicate that preg-
nenolone (400 ~M)* inhibits sterol biosynthesis in bovine 
corpus luteum homogenates at a site before the formation of 
mevalonic acid. The incorporation of 14c-acetate in proges-
terone by porcine corpora lutea in vitro can be decreased 
by several steroids (64 ~M), the precise site at which in-
hibition occurs has not been determined (Cook et a1. 25 ). 
None of these steroids, however, could influence the proges-
terone synthesis from endogenous tissue sources. The rela-
tively large tissue pools of cholesterol and cholesterol 
esters in testis and the uptake of cholesterol from 
blood26 , 27 make it unlikely that inhibition of cholesterol 
biosynthesis is of importance for the regulation of steroi-
dogenesis. 
*When possible, the concentrations of inhibitors necessary 
for 50% inhibition, are given. 
24 
Inhibition of cholesterol side-chain cleavage 
Pregnenolone (30 ~M) has been shown to inhibit the 
side-chain cleavage of radioactive cholesterol in bovine 
corpus luteum28 , 29 , in bovine adrenal cortex30 and in rat 
testis rnitochondria 29 . Koritz 30 ' 31 has proposed that ACTH 
increases mitochondrial permeability for pregnenolone, 
thereby lowering intrarnitochondrial pregnenolone concentra-
tions and relieving the inhibition of steroidogenesis. How-
ever accumulation of pregnenolone, as caused by inhibition 
of 6 5 ,36-hydroxysteroid dehydrogenase in rat adrenal sec-
tions by the addition of cyanoketone does not result in in-
hibition of endogenous pregnenolone synthesis 32 ' 3 ~ sugges-
ting that cholesterol side-chain cleavage is not signifi-
cantly affected by large intracellular pregnenolone concen-
trations. 
Testosterone was also found to be an inhibitor of the 
cholesterol side-chain cleaving activities in rat testis 
mitochondria in vitro29 , 34 and in the rat adrenal gland 1a 
. 35 35 ~ Colby reported that the rat adrenal side-chain 
cleaving activity was increased after orchiectomy and this 
effect could be reversed by testosterone administration. 
This probably reflects the influences of testosterone on 
mitochondrial cytochrome P 450 levels
36 
and on NADH-oxidase 
activity which will be described later. 
The extent to which exogenous radioactive cholesterol 
enters the endogenous mitochondrial pool is unknown. There-
fore formation of radioactive isocaproic acid or radioac-
tive pregnenolone may not reflect changes in cholesterol 
side-chain cleaving activities. In light of this and the 
findings of Cook 25 and Farese 32 , it may be concluded that 
the occurrence of inhibition of cholesterol side-chain 
cleavage28- 30 , 34 , 35 needs verification by measuring steroid 
production from endogenous sources. 
25 
Inhibition of 11/l-hydroxylation 
Corticosterone, when administered in vivo 37 or corti-
sol and deoxycorticosterone (10 ~M), when added in vitro 38 , 
inhibited the endogenous production of corticosterone by 
isolated rat adrenals. While studying this effect, Sauer 19 
observed that NADH-oxidase was markedly inhibited and he 
suggested that interference with the electron transport 
chain decreased the rate of succinate-supported steroid 
lls-hydroxylation by interfering with the reversed electron 
transport. NADH-oxidase inhibition by corticosterone (10 ~M) 
. 39 40 has also been reported for plg heart sarcosomes 1 
41 Investigations by Sharma et al. have drawn attention 
to the inhibiting influence of testosterone (10 vM) and 
androstenedione (10 
Yi!E£· Testosterone 
on the 11S-hydroxylation step in 
vM) and other androgenic steroids 
the site of NADH-can also inhibit electron transfer at 
oxidase in pig heart sarcosomes 40 Treatment of rats with 
pharmacological doses of testosterone reduces corticostero-
ne production and this is accompanied by a marked decrease 
in 11S-hydroxylase activities and mitochondrial cytochrome 
P450 levels in the adrenal gland (Colby and Brownie
36
,
42
,
43 ) 
Orchiectomy results in an 
ty, which can be reversed 
15 Burrow et al. have 
increased 11S-hydroxylase activi-
35 44 by a testosterone therapy ,_ 
shown that high concentrations of 
cortisol (1 mM) decrease the aldosterone production, proba-
bly by inhibiting adrenal protein synthesis 15- 17 However, 
Weinstein and Kliman 18 demonstrated more recently that lower 
doses (10 vM) of cortisol and 11-deoxycortisol had no effect 
on the biosynthesis of deoxycorticosterone, corticosterone, 
and aldosterone_ The observation that high concentrations 
of testosterone (300 vM) blocked adrenal protein synthesis 
and the steroidogenic effect of ACTH is of some inte-
rest16,17. 
Therefore it may be concluded that low concentrations 
of certain steroids may interfere with electron transport 
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in the respiratory chain and very high concentrations with 
protein synthesis 
Inhibition of 21-hydroxylation 
Weinstein and Kliman demonstrated18 that the addition 
of 17a-hydroxyprogesterone or 17a-hydroxypregnenolone 
(100 ~M) to rat adrenal glornerulosa tissue decreases the 
endogenous production of deoxycorticosterone and cortico-
sterone, resulting in a reduced in vitro production of al-
dosterone. The reduced production could be explained by an 
interference with the only hydroxylation step which the bio-
synthesis of all these steroids has in common, the 21-hydro-
xylation. Additional interference with llS- or IS-hydroxy-
lation, however, cannot be excluded. The 21-hydroxylation 
of pregnenolone and 17a-hydroxypregnenolone in the bovine 
adrenal gland can be inhibited by androstenedione, testos-
terone and dehydroepiandrosterone (20 ~M) 45 . 
Inhibition of 17a-hydroxylation 
The enzyme !?a-hydroxylase is inhibited by its product, 
46 17a-hydroxyprogesterone (60 ~M) . This enzyme can also be 
inhibited by 2Da-dihydroprogesterone and l7a,20a-dihydroxy-
l 4-pregnen-3-one (Inano et al. ) . 
Inhibition of C17,20-lyase 
47 Huseby et al. presented the first evidence indica-
ting that progesterone may have an inhibiting effect on the 
48 
c 17 20-lyase of mouse testis. Mahajan and Samuels and oth~rs 13 reported a similar effect in rat testis hornogena-
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tes and more recently it was shown that dilution of the 
labelled substrate 17~-hydroxyprogesterone with non-labelled 
17a-hydroxylated progesterone is not responsible for the 
competitive inhibition observed49 . 
Neher and Kahnt 13 reported inhibition of the c 17 , 20 -
lyase by a number of steroids, e.g. pregnenolone and dehy-
droepiandrosterone inhibit the side-chain cleavage of 17a-
hydroxypregnenolone and progesterone and 20a(and S)-dihy-
droprogesterone inhibit the side-chain cleavage of 17a-
hydroxyprogesterone. The effects of 20a(and S)-dihydropro-
gesterone has been confirmed by Inane et al. 1 . In addition 
deoxycorticosterone and 17a,20a-dihydroxy-4-pregnen-3-one 
were found to be competitive inhibitors of this enzyme 
(see 1.1.2). The kinetics of the c 17 , 20-lyase in human 
adrenal glands were investigated in more detail by Jensen 
~. 11 , 12 . The side-chain cleavage of 17a-hydroxypregne-
nolone (Km = 0.4 ~M) was noncompetitively inhibited by de-
hydroepiandrosterone (Ki = 5 ~M) , the tissue concentrations 
of the inhibitor were found to be in the order of 1.5 ~MSO 
They postulated that this inhibition might contribute to 
the control of human adrenal dehydroepiandrosterone biosyn-
thesis. 
Inhibition of t.~38-hydroxysteroid dehydrogenase 
The conversion of ~ 5 ,3s-hydroxysteroids to ~ 4 ,3-oxo­
steroids requires a ~ 5 ,3e-hydroxysteroid dehydrogenase and 
a 65 ,6 4-isomerase. The overall rate of the reaction from 
~ 5 ,3e-hydroxysteroids to ~ 4 ,3-oxosteroids estimates the 
rate of dehydrogenase reaction because the 65 ,6 4-isomerase 
reaction is much faster51 . Much of the knowledge of 65 ,3s-
hydroxysteroid dehydrogenase has been derived from experi-
ments with the bacterial enzyme from Pseudomonas Testoste-
~· Many inhibitors have been found (table l). Two models 
for the regulation of A5 ,3S-hydroxysteroid dehydrogenase 
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activity in vivo were proposed: 
Studies of Wiener and Allen9 ' 10 have shown that the 
placental dehydrogenase 
competitively inhibited 
20a-dihydroprogesterone 
(K for pregnenolone 2 ~M) is non-
m 
by progesterone (Ki = 10 ~M) and 
(Ki = 3 ~M) , that is at concentra-
tions comparable to those found in the placenta (5-10 ~M 
and 1 ~M respectively). 
The conversion of pregnenolone to progesterone by rat 
testis (Km = 67 ~M) was inhibited by 7a-hydroxyandrostene-
dione (Ki =57 ~M) 3 . Testicular ?a-hydroxylase activity, 
however, is low and is inhibited .by 7a-hydroxyandrostene-
dione itself and by 7a-hydroxytestosterone. Data on tissue 
levels of 7a-hydroxyandrostenedione are not available. 
Inhibition of ~ ~~4-steroid isomerase 
57 Ewald presented evidence for the existence of two 
distinct isomerases in bovine adrenal glands and demonstra-
ted that the isomerization of 5-pregnene-3,20-dione, 17a-
hydroxy-5-pregnene-3,20-dione and 5-androstene-3,17-dione 
can be inhibited by their corresponding 6 5 ,36-hydroxyste-
roids at concentrations of 30 ~M58 Since the oxidation of 
3S-hydroxysteroids is rate-limiting in the conversion of 
6 5 ,3s-hydroxysteroids to 6 4 ,3-oxosteroids 51 , inhibition of 
the isomerases is of little consequence for steroid biosyn-
thesis. 
Inhibition of 17~- hydroxysteroid dehydrogenase 
The 17S-hydroxysteroid dehydrogenase, the enzyme in-
volved in the last step in testosterone biosynthesis in the 
rat, can be inhibited by oestradiol (6 ~M) 14 and by 7a-
hydroxyandrostenedione (500 ~M) but is activated by 7a-
29 
3 hydroxytestosterone (500 ~M) . 
Inhibition of 20a-hydroxysteroid dehydrogenase 
Oestradiol (K. = 
1 
oestrone (Ki = 12 ~M) 
5 vM) 61 , oestriol (K. 
1 
were found to inhibit 
= 82 vM) and 
the 20o.-reduc-
tion of progesterone (Krn = 470 ~M) by the placental 2Do.-
hydroxysteroid dehydrogenase and are thought to take part 
in the regulation of this enzyme activity9 ' 10 
Inhibition of steroid sulfatase 
4-6 It was demonstrated by Notation and Ungar and by 
Payne et al. ?,B that a large number of steroid metabolites 
inhibit the steroid sulfatase activity of human and rat 
testis. However, it is not certain what role, if any, the 
steroid sulfates play in steroid hormone production - this 
will be discussed later (see part II). It is suggested that 
modulation of the sulfatase activity by free steroids may 
regulate the release of essential free steroid precursors 
of testosterone. The reported Ki-values are in the same 
range as the K -values for the different steroid sulfates 
m 
(1-10 ~M). The concentrations of dehydroepiandrosterone and 
its sulfate in human testis were recently estimated by 
62 Ruokonen and are 0.03 ~M and 1 ~M respectively. It is 
difficult to conclude whether the larger concentration of 
the steroid sulfate is a result of inhibition of the sul-
fatase or, more likely, of a low sulfatase level when com-
pared to 36(and 176)-hydroxysteroid dehydrogenase activi-
ties. 
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Miscellaneous inhibitions of steroidogenesis 
Two other compounds, which may influence steroidogene-
sis through inhibition of the enzymes involved and which 
may have physiological significance are 3' ,5'-cAMP and some 
indoles. 
The postulated intracellular mediator of trophic hor-
mone action, 3' ,5'-cAMP stimulates pregnenolone forrnation63 
In addition to this, 3' ,5'-cAMP at high concentrations can 
inhibit the ~ 5 ,3s-hydroxysteroid dehydrogenase in rat adre-
nal64-66 and ovarian tissue67 . The conclusion drawn from 
these studies is that 3' ,5'-cAMP can compete with NAD+-
dependent steroid enzymes for the available NAD+ or that 
3' ,5'-cAMP stimulates reactions that compete for NAD+ 65 , 68 . 
The significance of this effect of 3' ,5'-cAMP in the control 
of steroidogenesis requires further clarification66 
Recently Kinson69 and Ellis 70 observed that melatonin 
and serotonin (2 vM), when added in vitro, can inhibit se-
veral steps of rat testicular androgen biosynthesis. These 
findings will undoubtedly stimulate further research on the 
significance of these indoles for the function of the tes-
tis. 
Synthetic inhibitors of steroid biosynthesis have proved to be a 
useful tool for studying the effects of decreased steroid 
biosynthesis. A steroidal cyanoketone, for example, inhi-
bits the ~ 5 ,3e-hydroxysteroid dehydrogenase and ~ 5 ,~ 4 -
isornerase71•72 and in high concentrations the cholesterol 
73 
side-chain cleavage Administration of this compound to 
pregnant rats and mice can provide an experimental model 
f l d h . 7 4 d h d f 75' 76 or congenita a renal yperplasla an ot er e ects 
due to a deficiency of ~ 5 ,38-hydroxysteroid dehydrogenase. 
Experiments with isoxazol produce similar results 75 r 77 . 
Ovulation in immature rats can be prevented by this cyano-
ketone, apparently also a result of inhibited progesterone 
31 
biosynthesis 78 
Nonsteroidal inhibitors have been reviewed by Gaunt 
et al. 79 and by Dorfman and Ungar 80 . Further publications 
concerning their effects on testicular steroid biosynthesis 
are from Tarnaoki and Shikita81 , Inano et al. 82 , Bloch et 
al. 76 and Goldman 83 • 
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table 1 INHIBITION OF STEROID BIOSYNTHESIS BY STEROIDS IN VITRO 
enzyme (and source) 
cholesterol side-chain 
cleaving enzyme 
bovine corpus luteum 
bovine adrenal cortex 
rat adrenal gland 
rat testis 
11$-hydroxylase 
rat adrenal gland 
21-hydroxylase 
rat adrenal (glomerulosa) 
. 
bovine adrenal cortex 
17c:t-hydroxylase 
rat testis 
substrate 
cholesterol (exogenous) 
endogenous precursors 
. 
deoxycorticosterone 
endogenous precursors 
. 
deoxycorticosterone 
endogenous precursors 
progesterone 
pregnenolone 
17d-hydroxypregnenolone 
progesterone 
inhibitor 
pregnenolone 
testosterone (in vivo) 
pregnenolone 
testosterone 
corticosterone 
deoxycorticosterone 
cortisol 
androstenedione 
testosterone 
(in vivo) 
17a-hydroxyprogesterone 
17m-hydroxypregnenolone 
testosterone and 
dehydroepiandroste-
rone 
17~-hydroxyprogesterone 
20~-dihydroprogesterone 
17«,20a-dihydroxy-4-
pregnen-3-one 
K. (type of * References ~ inhibition ) 
no inhibition 
Ki~IB ~M (camp.) 
28,29 
30 
35 
29 
29,34 
37 
38 
15 
38 
18 
41 
41 
35,36,42,43 
22 
22 
45 
46 
1 
1 
w 
,. 
table 1 (continued} 
enzyme (and source) 
c 17 , 20 -lyase 
mouse testis 
rat testis 
" human adrenal 
6 5 ,3B-hydroxysteroid 
dehydroqenase 
Pseudomonas Testosteroni 
" bovine adrenal cortex 
bovine corpus luteum 
human placenta 
rat testis 
human testi:o; 
substrate 
l7tt-hydroxyprogesterone 
" 17«-hydroxypregnenolone 
dehydroepiandrosterone 
" pregnenolone 
dehydroepiandrosterone 
pregnenolone 
dehydroepiandrosterone 
pregnenolone 
androstenediol 
inhibitor 
progesterone 
progesterone 
20~(S)-dihydroproges-
terone 
17~,20a-dihydroxy-4-
pregnen-3-one 
deoxycorticosterone 
dehydroepiandroste-
rene 
17a-hydroxyprogeste-
rene 
androstenedione 
oestradiol 
17~-hydroxyprogeste-
rene 
progesterone 
androstenedione 
118-hydroxyandroste-
nedione 
androstenedione 
progesterone 
20~-dihydroprogeste-
rene 
20S-dihydroprogeste-
rene 
oestradiol 
7a-hydroxyandroste-
nedione 
oestradiol 
K. (type of References 
1 inhibition*) 
---
47 
(camp.) 13,48,49 
1,13 
K. = 9 p.M(comp.) 1 1 
K.= 3 fJM(comp.) 1 
K7= 5 pM(comp.) !1,12 
1 
K1 =30 J-lM(comp.) 52 
K1=30 JJ.M(comp.) 52 K1= 2 uM(comp.) 52 53 
54 
{camp.) 54 
34 
54 
K1=10 J.IM(non-c.) 9,10 K1= 3 ~M(non-c.) 9 1 l Q 
K. = 4 
"M 10 1 
14 
Ki""57 f<M(comp.) 3 
55 
w 
'" 
table 1 (continued) 
enzyme (and source) 
fl 5 1 lJ. 4- iSOmerase 
bovine adrenal cortex 
guinea pig adrenal gland 
guinea pig liver 
Pseudomonas Testosteroni 
20~-h~drox~steroid 
dehydrogenase 
human placenta 
substrate 
5-pregnene-3,20-dione 
5-androstene-3 1 17-dione 
5-pregnene-3,20-dione 
17"-hydroxy-5-pregnene-
3,20-dione 
5-androstene-3,17-dione 
androstenedione 
testosterone 
" 
" 
progesterone 
inhibitor 
progesterone 
pregnenolone 
17«-hydroxypregneno-
lone 
dehydroepiandrosterone 
oestradiol 
7~-hydroxyandrostene-
diane 
androstenedione 
dehydroepisulfate 
testosterone 
oestriol 
oestrone 
oestradiol 
K. (type of * References ~ inhibition ) 
Ki=70 j.~.M(comp.) 
K.=82 
"M 
K7=12 
"M 
K7= 5 
"M 
' 
56 
56 
57,58 
57,58 
57,58 
14 
3 
59 
59 
60 
91 10 
9,10 
61 
w 
"' table l (continued) 
enzyme (and source) 
steroid sulfatase 
human testis 
rat testis 
*camp. = competitive 
non-c.= non-competitive 
substrate 
pregnenolone sulfate 
and dehydroepiandros-
terone sulfate 
pregnenolone sulfate 
dehydroepiandrosterone 
sulfate 
androstenediol sulfate 
oestradiol sulfate 
inhibitor K. (type of * References ~ inhibition ) 
pregnenolone 8 
20u-dihydroprogeste- 8 
rene 
5-pregnene-38,20~-diol K."'l5 !JM(comp.) 8 
38,21-dihydroxy-5- 1 8 
pregnen-3-one 
Sa-androstane-3u,l78- K.=40 )JM(comp.) 8 
diol 1 
testosterone 5 '6 
!~:;;~~~~~~~~~~~=~~i~~e ~~=li ~~~~~:~:~ 5 5 5 
dehydroepiandrosterone K~= 8 ~M(comp.) 5 '6 
s~-androstane-3a,l7B- K.= 3 
"M 7 
dial 1 
5a-androstane-3B,l7B- K.=l JJM(comp.) 5 '7 
dial 1 
testosterone K.=l2 !JM(comp.) 5,6,7 
androstenediol 1 7 
oestradiol 7 
oestradiol K.=l6 !JM(comp.) 7 
testosterone K7=13 
"M 7 1 
1.2 Materials and methods 
1.2.1 Materials 
solvents and reagents were obtained from UCB, Brussels 
and Merck, Darmstadt. Solvents were distilled before use. 
Diethylether was treated with a concentrated ferrosulphate 
solution prior to distillation and was used within a,. week. 
Toluene, when used for gas chromatography, was redistilled. 
NADPH, glucose-6-phosphate and the glucose-6-phosphate de-
hydrogenase were purchased from Boehringer, Mannheirn. Bo-
vine serum albumin was purchased from Povite Products, 
Amsterdam. 
Steroids were purchased from Steraloids Inc., 20o.-dihydropro-
gesterone from Ikapharm and the 17o.,20o.-dihydroxy-4-pregnen-
3-one was a gift from the Steroid Reference Collection of 
the Medical Research Council, Great Britain, this steroid 
is now commercially available (Steraloids). 178-Ureido-1,4-
androstadien-3-one was obtained through the courtesy of 
Dr. G.E. Arth, Merck Sharpe and Dohme Research Laboratory, 
Rahway, u.S.A .. These steroids were used without further 
purification. 
Radioactive steroids: 7a- 3H-l 7a-Hydroxyprogesterone ( 15 Ci/mM) , 
14 . 14 4- C-17a-hydroxyprogesterone (37 mCl/mM) 1 4- C-testoste-
rone (58 mCi/mM), 1,2-3H-testosterone (37 Ci/mM) and 4- 14 c-
androstenedione (60 mCi/mM) were obtained from Radiochemi-
cal Centre, Arnersharn and 1,2- 3H-progesterone (36 Ci/mM) and 
14 4- C-progesterone (57 rnCi/mM) from the New England Nuclear 
Corporation, Boston. 
7a- 3H-and 4- 14c-Labelled 17a,20a-dihydroxy-4-pregnen-
3-one were prepared from radioactive 17a-hydroxyprogeste-
rone using an enzymatic reduction with a soluble rat testis 
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preparation (80 mg protein) and a NADPH .regenerating system 
under nitrogen for 1 hour. After extraction the 17a,20a-
dihydroxy-4-pregnen-3-one was purified by chromatography on 
paper in a Bush AII system for 16 hours, the yield exceeded 
50%. 
All radioactive steroids were purified by paper chro-
matography and thin-layer chromatography when necessary. 
1.2.2 Techniques 
Radioactivity was measured with a liquid scintillation counter 
(Packard model 3375 or Nuclear Chicago, Mark I) to an accu-
racy better than 1%. Quench corrections were usually cal-
culated from external standard ratios. The samples were 
counted in a solution containing 4 g diphenyloxazole (PPO) 
and 40 mg 1,4-bis-2-(5-phenyloxazolyl)-benzene (POPOP) per 
. 84 3 14 litre or a modified Bray's solut~on . When Hand C were 
measured simultaneously, the 3H; 14c ratio in the samples 
was kept within 1 and 100. 
Chromatographic techniques 
Paper chromatography was carried out on Whatman No. 20 
paperstrips in a Bush AII system (petroleum ether:methanol: 
water= 100:70:30, by val.) or 
ether:toluene:methanol:water = 
a Bush BI system (petroleum 
85 25:25:35:15, by vol.) . 
Thin-layer chromatography (t.l.c.) was performed on 
precoated silicagel plates (Merck F 254 , 20x20 ern). Samples 
for gas chromatography were purified on t.l.c. plates which 
had been prerun in toluene:methanol = 9:1 (by val.). 
Detection of radioactive steroids on paper chromato-
grams was carried out with a Packard radiogramscanner {mo-
del 7200) and on t.l.c. plates with a Panax thin-layer 
scanner. Gas chromatography (g.l.c.) was carried out on a 
Hewlett-Packard Biomedical analyser, equipped with a tri-
tium electron capture detector. The stationary phase con-
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sisted of 1% QF-1 coated on Gas-Chrom Q (80-100 mesh, 
Applied Science) and argon {5% methane) was used as carrier 
gas. 
Acetylations were carried out overnight in an acetic anhydri-
de pyridine mi~ture (1:1). 
Protein determinations were carried out as described by Lowry 
86 
et al. . 
1.2.3 Preparation of tissue fractions and incubations 
Rats of the Wistar strain {weight 200-250 g) were kil-
led by cervical fracture and subsequent bleeding. Rabbits 
(New Zealand White-strain, 2.5-3.5 kg) were anesthetized 
with Hypnorm (Philips-Duphar) and the testes were removed. 
After removal of the capsule the testes were homogenized in 
0.25 M sucrose using a Potter Elvejhem homogenizer. For 
fractional centrifugation a Sorvall centrifuge (RC-2B) and 
a Beckmann ultracentrifuge (L2-6SB, type 50 rotor) were 
used. The following fractions were prepared: the SOOxg su-
pernatant (15 min), the 800-105,000xg precipitate (60 min, 
combined microsomal and mitochondrial preparation) and the 
105,000xg supernatant (60 min). 
Incubations were carried out in Krebs-Ringer bicarbo-
nate buffer (pH 7.4). The substrate 17a-hydroxyprogesterone, 
7a- 3H-17a-hydroxyprogesterone (l-3x10 6 dpm} and the steroid 
inhibitor were dissolved in methanol together with 1 ~g 
Tween-20 in the incubation tube and the methanol was evapo-
rated. The mixture was dissolved in a small volume of buf-
fer, containing NADPH {1 mM), glucose-6-phosphate (10 mM) 
and glucose-6-phosphate dehydrogenase. The reaction was 
started by adding the tissue preparations. The final volume 
was 1 to 1.5 ml. For some experiments the tissue was minced 
with scissors, and then approximately 100 mg was weighed 
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Fig. 2. Conversion of 17a.-hydroxyprogesterone (3 pM) by a 800 x g supernatant of 
rabbit testis, plotted against the time. Each value is the mean of a duplicate 
estimation. 
and transferred to an incubation tube, containing the in-
cubation medium (plus 20 mM glucose) . The incubation was 
started by addition of the substrate mixture. Rabbit testes 
were incubated at 37°c87 but rat testes were incubated at 
33°C, because of the lower scrotal temperature88 . All incu-
bations were carried out in a 95% oxygen, 5% carbondioxide 
atmosphere. After preliminary experiments an incubation 
time of 30 min was chosen for incubation experiments with 
rabbit testis (fig. 2) and 60 min for rat testis prepara-
tions. 
1.2.4 Extractions and isolation of steroids 
The incubation was stopped by the addition of 2-3 ml 
ethyl acetate containing 17~-hydroxyprogesterone, andros-
tenedione, testosterone, 17a,20a-dihydroxy-4-pregnen-3-one 
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14 4 14 (50 "g each) plus 4- C-testosterone (10 dpm), 4- c-
androstenedione (10 4 dpm), 4- 14c-17a-hydroxyprogesterone 
(5. 10 3 dpm) and in some experiments 4- 14c-l 7a, 20o.-dihydroxy-
4-pregnen-3-one (5.!0 3 dprn). After extraction with 3x2 ml 
of ethyl acetate, the combined extracts were washed once 
with water and evaporated to dryness. Separation with paper 
chromatography (Bush AII) gave four fractions containing: 
1) 17a,20a-dihydroxy-4-pregnen-3-one, 2} testosterone, l?a-
hydroxyprogesterone and Sa-androstane-3o.(S) ,178-diol, 3) 
androstenedione and 3o.(S)-hydroxy-5a-androstan-3-one. They 
were located on the paperstrip under u.v. light (254 nm) or 
by scanning for radioactivity. The steroids were eluted with 
10 rnl methanol or 10 ml methanol-water {9:1). Fraction 1 
was further purified with paper chromatography (Bush BI}. 
Fractions 2 and 3 were acetylated and subjected to respec-
tively t.l.c. (toluene:ethyl acetate 1:4, by vol.) and pa-
per chromatography (Bush AII). In some experiments a rela-
tively small amount of 5u-androstanedione was found, as 
identified by its Rf-value in the Bush AII system and its 
non-acetylatable character. The isolated steroids (as ace-
tates) were counted for 3H and 14c. The recovery from the 
14 isolation procedure was calculated from the c content of 
the sample. These data were subsequently used to calculate 
the formation rate of the steroid product. 
1.2.5 Perfusions 
The technique for in vitro perfusion of rabbit testis 
is described in Materials and Methods of the second part of 
this thesis (paragraph 2.3.2). The same technique was used 
for the perfusion experiments with inhibitor. The substrate 
3 1,2- H-progesterone was dissolved in approximately 4 ml of 
0.15 M NaCl solution {5% albumin, 4 ~g Tween-20) and was 
infused continuously into the testicular arterial blood at 
a constant rate, the doses varied from 106 to 3xl06 dpm 3H 
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per 30 min. The inhibitor was introduced in the same way 
over a 20 min period, starting at a suitable time (para-
graph 1.4.3). The testicular venous blood was collected in 
30 min fractions. 4- 14c-Steroids (see above) were added to 
the plasma without carrier steroids. _The steroids were iso-
lated and counted as described for the incubation samples. 
Testosterone acetate was hydrolized (80% methanol in water, 
1M NaOH), purified by t.l.c. (toluene:ethyl acetate 2:1, 
by val.), estimated 
acetate and counted 
by gas chromatography 
3 14 for H and c. 
1.2.6 Estimation of testosterone 
as the chloro-
Essentially the same method was used as described by 
Brownie et a1. 89 , except that 20a-dihydroprogesterone chlo-
roacetate was used as an internal standard during g.l.c. 
analysis. Precoated t.l.c. plates were used and benzene was 
replaced by toluene throughout the method. 
1.2.7 Estimation of 17a-hydroxyprogesterone 
The competitive protein binding assay for the estima-
tion of 17a-hydroxyprogesterone was similar to the method 
90 described by de Jong and van der Molen for progesterone, 
3 3 
replacing H-progesterone by H-17a-hydroxyprogesterone. 
The binding of 
to 19% when 10 
3 H-17a-hydroxyprogesterone decreased from 55 
ng of unlabelled 17a-hydroxyprogesterone was 
added. Accuracy and precision are given in table 2. 
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Table 2 ACCURACY AND PRECISION OF l7a-HYDROXYPROGESTERONE 
ESTIMATION 
amount 
added (ng) 
0 
10 
25 
50 
amount 
estimated 
1.8 
11.5 
24.0 
50 
(ng) 
S.D. (ng) n 
0.3 
1.0 
1.7 
2 
6 
4 
4 
4 
When analysing biological samples, three aliquots of 
different sizes were taken from the purified !?a-hydroxy-
progesterone containing fraction and were subjected to a 
competitive protein binding assay. This fraction contains 
3 testosterone, which competes with H-17a-hydroxyprogeste-
rone for the binding protein. However, cross-reaction is 
low (4%); addition of 10 ng of testosterone to 1 ng of 17a-
hydroxyprogesterone caused a decrease in binding from 48 
to 43%, corresponding to 0.4 ng of l?a-hydroxyprogesterone. 
Nevertheless the purification step on t.l.c. prior to the 
assay was repeated once in order to achieve a good separa-
tion from testosterone. 
1.2.8 Estimation of 17a,20a-dihydroxy-4-pregnen-3-one 
The observation, that the 17a,20a-dihydroxy-4-pregnen-
3-one can be oxidized with periodic acid to androstenedio-
91,92 
ne , was used as a starting point for estimation. The 
method is summarized in table 3. The high sensitivity of 
electron capture detection allows accurate detection of the 
testosterone chloroacetate. 
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Table 3 ESTIMATION OF l7a,20a-DIHYDROXY-4-PREGNEN-3-0NE 
1. Addition of 7a- 3H-17a,20a-dihydroxy-4-pregnen-3-one to 
plasma sample or acetone extract of tissue. 
2. Defatting of the tissue extracts. 
3. Alkaline ether extraction. 
4. Paper chromatography (Bush BI), followed by t.l.c. 
5. Oxidation with HI04 to androstenedione, t.l.c. 
6. Enzymatic reduction of the 17-oxo group and conversion 
to testosterone chloroacetate, t.l.c. 
7. - Sampling for counting of tritium 
- Sampling for mass determination by gas chromatography 
with electron capture detection. 
Tissue extractions 
Testes of rats and rabbits were collected as described 
and were frozen in liquid nitrogen when not processed imme-
diately. Testes were homogenized in 15 ml acetone (Ultra-
Turrax) and to each sample approximately 50,000 dpm of 7a-
3H-17a,20a-dihydroxy-4-pregnen-3-one (15 Ci/mM) (and 5,000 
3 dpm 7a- H-17a-hydroxyprogesterone) was added. The homogena-
tes were centrifuged and the pellets were resuspended in 
10 ml ethanol-aceton (l:lf by vol.) and recentrifuged. This 
was repeated once and the combined extracts were concentra-
ted under reduced pressure in a rotating evaporator to a 
volume of 2-3 ml. After transferring the extract to a cen-
trifuge tube, warm methanol was added until a 70% methane-
lie solution was obtained. Defatting was achieved by free-
zing at minus 25°C followed by centrifugation. The solution 
was again concentrated to the water phase and extracted 
with diethylether (4xl0 ml). The combined extracts were 
washed twice with water (5 ml) and the ether was evapora-
ted. 
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Plasma samples 
After addition of the 7a- 3H-17a,20a-dihydroxy-4-preg-
nen-3-one, the plasma samples were subjected to the alkaline 
ether extraction procedure. 
Estimation method 
The extract was chromatographed on paper in a Bush BI 
system. The steroid was located by scanning for radioacti-
vity and then eluted with 10 ml 90% methanol (the 17a-
hydroxyprogesterone containing fraction was also eluted and 
estimated with the competitive protein binding assay). The 
eluate was concentrated and further purified with t.l.c. 
(toluene: ethyl acetate 2:1). The 17a,20a-dihydroxy-4-preg-
nen-3-one fraction, eluted by methanol was concentrated to 
a volume of 1 ml. Oxidation was performed by addition of 
0.5 ml acetic acid and 1.0 ml of 1% periodic acid solution 
(Riedel-Haen). 'After 1 h in the dark 8 ml of ethyl acetate 
was added and after mixing the solution was washed with 
1x2 rnl water, 2x2 ml of a 8% sodium bicarbonate solution 
and again with 1x2 ml of water. The ethyl acetate was evapo-
rated to dryness and the residue was purified with t.l.c. 
(toluene:ethanol 9:1, by vol.). The androstenedione con-
taining region was scraped off and eluted with toluene. 
This fraction was reduced to testosterone by 100 ~g sodium 
,, 
borohydride in 0.5 ml ethanol (2 h at 4°C). In later expe-
riments the reduction was carried out by incubation with a 
hydroxysteroid dehydrogenase preparation (Worthington) 93 : 
Androstenedione and 2 ~g of Tween-20 were dissolved in 1 ml 
Krebs-Ringer bicarbonate buffer (pH 7.4) containing NADH 
(50 mM) and 0.1 U. of the enzyme was added. After five minu-
tes of incubation at room temperature, extraction by ethyl 
acetate was carried out. The extracts were concentrated to 
dryness, chloroacetylated, estimated by gas chromatography 
and counted for 3H-radioactivity. The amount of 17a,20a-
dihydroxy-4-pregnen-3-one was calculated with aid of the 
3 
recovery of the H-label. 
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1.2.9 Localization of the 20a-hydroxysteroid dehydrogenase 
Dissection procedure 
Interstitial tissue and seminiferous tubules of two rat 
testes were separated using the wet dissection technique of 
Christensen and Mason94 . The isolated tissues were washed 
2-3 times in a small volume of Krebs-Ringer bicarbonate 
buffer (pH 7.4) in order to remove the soluble 20a-hydroxy-
steroid dehydrogenase activity which was leaked from broken 
cells. Tissue fragments were recollected through centrifu-
gation at approximately 300xg for 1 min. The tubular frac-
tion was homogenized by a Potter Elvejhem homogenizer in 
10 rnl 0.1 M phosphate buffer (pH 7.0) containing 5 mM EDTA. 
The interstitial tissue was homogenized in l ml of phos-
phate buffer. Samples of the total homogenates were removed 
and used for protein determinations. Sonicated samples were 
assayed for phenyl esterase activity by measuring the rate 
of hydrolysis of p -nitrophenylacetate in 0.1 M Tris-HCl 
buffer (pH 8.0) 95 . 
The total homogenate was centrifuged at 10,000xg for 
15 min, the supernatant was taken and centrifuged at 
lOS,OOOxg for 60 min. The 105,000xg supernatant was assayed 
for 20a-hydroxysteroid dehydrogenase activity and protein. 
2Ch-Hydroxysteroid dehydrogenase 
The preparations were incubated in 0.1 M phosphate 
buffer (pH 7.0) containing 1 mM NADPH, 10 mM glucose-6-
phosphate and glucose-6-phosphate dehydrogenase. The tubu-
lar fraction (2.8 mg protein/incubation) was incubated in 
2 ml of buffer and the interstitial tissue fraction (0.18 
mg protein/incubation) in 0.5 ml volume. Incubation was 
started by introduction of the substrate 17a-hydroxyproges-
terone (approximately 40,000 dpm 4- 14C-17a-hydroxyproges-
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terone, final concentration varied from 1-60 vM) and 30 
respectively 60 min later the reaction was stopped by addi-
tion of ethyl acetate. Carrier steroids and 10,000 dpm 
7a-3H-17a,20a-dihydroxy-4-pregnen-3-one were added and the 
product was isolated as described in paragraph 1.2.2. The 
net conversion was calculated from the 3H and 14c content 
of the purified product. The velocity was constant for 
60 min and a linear relationship was found between velocity 
and substrate concentration in both preparations. Enzyme 
activities were calculated on basis of the conversion at 
60 vM substrate. The K -value of the partially purified 
m 2 
enzyme was reported as 65 ~M . Higher substrate concentra-
14 tions resulted in decreased percentages of C conversion 
and inaccurate measurements of radioactivity. 
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1.3 Metabolism of progesterone and 17a-hydroxyproges 
terone and the formation of 17a,20a-dihydroxy-4-
pregnen-3-one 
1.3.1 Metabolism of progesterone and 17a-hydroxyprogesterone 
It is well established that testicular tissue can con-
vert progesterone and 17a-hydroxyprogesterone to androste-
. 96 98 99 
nedlone and testosterone ' ' . When using these substra-
tes, other products are formed in addition to the steroids 
known to be involved in androgen biosynthesis. For example, 
the formation of Sa-reduced steroids, 3a(S)-hydroxysteroids 
and 20a(B)-hyd.roxysteroids has been reportedlOO,lOl 
The possible pathways for the metabolism of 17a-hydro-
xyprogesterone are given in fig. 3. In order to obtain a 
correct estimate of the c 17 , 20 -lyase activities in rat and 
rabbit testes, it was necessary to identify the main c 17 , 20 -
lyase products formed in our incubation and perfusion experi-
ments. In addition, the formation of the potential inhibi-
tor 17 a, 2 O.a~dihydroxy- 4-pregnen- 3-one under several experi-
mental condi~ions was investigated. 
Identification of metabolites 
Five different metabolites were isolated after incuba-
tion of homogenates of~ testes with 7a- 3H-17a-hydroxy-
progesterone. In addition to labelled androstenedione and 
testosterone, the presence of labelled 3(aors)-hydroxy-Sa-
androstane-17-one, 5a-androstane-3(aorB) ,l7S-diol and 17a, 
20a-dihydroxy-4-pregnen-3-one was established. 
The identification of these steroids was based on simi-
lar chromatographic behaviour of the free steroids, their 
acetates and their oxidation products, and that of referen-
ce compounds. The two 3-hydroxysteroids were expected as 
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Fig. 3. Some theoretical possibilities for metabolism of 17d-hydroxyprogesterone in 
the testis. 
products because the formation of these metabolites has 
been previously describedlOO,l0 2 . Recently this work was 
103-110 
confirmed by others . When the incubation period was 
limited to 30 or 60 minutes, the contribution of these two 
metabolites to the total of c 17 , 20-lyase products was less 
than 3% and could usually be neglected. Therefore the sum 
of androstenedione and testosterone reflects c 17 , 20-lyase 
activity. The 17a,20a-dihydroxy-4-pregnen-3-one was also 
isolated and identified;thus confirming previous 
reportslOl,lll 
Incubation of rabbit testis homogenates with 7a- 3H-
17a-hydroxyprogesterone revealed the formation of labelled 
3-hydroxysteroids and Sa-androstane-3,17-dione as by-pro-
ducts of androstenedione and testosterone. After isolation 
of the labelled 3-hydroxysteroids, samples were recrystal-
lized with eight different c 19-steroids and the presence of 
38-hydroxy-Sa-androstane-17-one and Sa-androstane-38,178-
diol was established (tables 4 and 5). The Sa-androstane-
3,17-dione fraction was not fully characterized. After a 
shorter incubation period (30 min) only the 36-hydroxy-Sa-
androstane-17-one contributed significantly to the total of 
c 17 , 20-lyase products. Rabbit testis also demonstrated 20a-
hydroxysteroid dehydrogenase activity and the identity of 
Table 4 RECRYSTALLIZATION OF 36-HYDROXY-Sa-ANDROSTAN-17-0NE, 
isolated from incubations of rabbit testis with 7~- 3H-
17~-hydroxyprogesterone. After isolation, the 3H-labelled meta-
bolite was recrystallized with 50 mg of carrier steroid 
Recrystallized from 
1. toluene/methylcyclohexane 
2. dioxane/cyclohexane 
3. methanol/water 
so 
Specific activity as 10- 3 x dpm/mg 
expt. 1 e~t. 2 
crystals mother- crystals mother-
32.4 
32.3 
3!.2 
liquor liquor 
55.1 
32.4 
31.4 
30.5 
30.2 
29.7 
45.0 
30.3 
17a,20a-dihydroxy-4-pregnen-3-one was confirmed by recrys-
tallization with the authentic steroid (table 6). Table 7 
summarizes the metabolic products of 17a-hydroxyprogeste-
rone. 
Table 5 RECRYSTALLIZATION OF Sa-ANDROSTANE-38,178-DIOL 
(see legend table 4) 
Recrystallized from 
l. toluene/methylcyclohexane 
2. dioxane/cyclohexane 
3. methanol/water 
Specific activity as 10- 3 x dpm/mg 
crystals 
9.16 
9.39 
9.50 
mother-liquor 
9.92 
Table 6 RECRYSTALLIZATION OF 17a,20a-DIHYDROXY-4-PREGNEN-3-0NE 
(see legend table 4) 
Recrystallized from 
1. methanol/cyclohexane 
2. toluene/cyclohexane 
3. toluene 
Specific activity as 10- 3 x dpm/mg 
expt. 1 expt. 2 
crystals mother-liquor crystals 
6.66 
6. 67 
6. 4 7 
7. 66 7. 06 
7.22 
6.84 
Table 7 STEROID METABOLITES isolated after incubations of 7a- 3H-
17a-hydroxyprogesterone with total testis homogenates 
RAT 
17a,20a-dihydroxy-4-pregnen-3-one 
androstenedione 
testosterone 
RABBIT 
17a,20a-dihydroxy-4-pregnen-
3-one 
androstenedione 
testosterone 
3(a,6}-hydroxy-5 -androstane-17-one 36-hydroxy-Sa-androstane-17-one 
Su-androstane-3{a,6) ,176-diol Su-androstane-36,178-diol 
Su-androstane-3,17-dione 
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1.3.2 Formation of 1U,20d-dihydroxy-4-pregnen-3-one 
During incubations of both rat and rabbit testes min-
ces and broken cell preparations 7a- 3H-17a-hydroxyprogeste-
rone was converted to labelled 17a,20a-dihydroxy-4-pregnen-
3-one. The quantities of this potential inhibitor isolated, 
demonstrate that this is a major metabolite (table 8). It 
was found that the largest amounts of 17a,20a-dihydroxy-4-
pregnen-3-one were in the soluble fraction, thus indicating 
that the 20a-hydroXysteroid dehydrogenase from rabbit tes-
tis is a soluble enzyme, which is in agreement with previous 
reports for the rat testis 1 ' 2 The activity present in the 
combined microsomal/mitochondrial fractions (800-lOS,OOOxg 
Table 8 FORMATION OF 3H-17a,20a-DIHYDROXY-4-PREGNEN-3-0NE 
(17,20-P). The conversion of 3H-17a-hydroxyprogeste-
rone {3 ~M) to 17,20-P and lyase products during incubation 
with several testis preparations is expressed as a percentage 
of the total amount of tritium per incubation (each tissue 
fraction was equivalen't to 100 mg of total testis tissue, 
wet weight). 
*not corrected for losses during the isolation procedure 
exp. animal preparation % 3H in % 3H in 
17,20-P lyase products 
. 
1 rat 800xg supernatant 15 58 
• 800-!0S,OOOxg pellet 4 54 
. 
lOS,OOOxg supernatant 23 0. 3 
2 rat 800xg supernatant 10 70 
minced testis 9 64 
3 rabbit 800xg supernatant 24 10 
• 800-lOS,OOOxg pellet 2 21 
• lOS,OOOxg supernatant 25 0. 2 
4 rabbit 800xg supernatant 15 17 
minced testis 6 14 
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pellet) can at least in part be explained by a contamina-
tion with the soluble fraction, because they were not was-
hed or recentrifuged. 
In the rabbit testis incubations, the amounts of 
cl7,20-lyase products, formed by the 800xg supernatant is 
half of that formed by the 800-lOS,OOOxg pellet. It is not 
likely, that the l7a,20a-dihydroxy-4-pregnen-3-one,formed 
by the cytosol,is responsible for the decreased c 17 , 20 -
lyase activity, since the final concentration of inhibitor 
was only 0.7 uM, which is too low to cause considerable 
inhibition (see paragraph 1.4.1). 
with 
When rabbit testis in vitro was continuously perfused 
3 7a- H-progesterone, labelled 17a,20a-dihydroxy-4-
pregnen-3-one was detected in the venous effluent (table 9). 
The figures shown for this metabolite, in contrast to those 
shown for testosterone, have not been corrected for losses 
during the isolation procedures, therefore the amounts pro-
duced were approximately twice as high as the figures sug-
gest. The amount of tritium incorporated into testosterone 
was found to be five to ten times higher than that incorpo-
rated into androstenedione. Thus the values for testostero-
Table 9 SECRETION OF 3H-17a,20a-DIHYDROXY-4-PREGNEN-3-0NE 
( l 7, 20-P) Arm 3H-TESTOSTERONE (T) BY RABBIT TESTES. 
3H-Steroids ware isolated from the venous effluents after in 
vitro perfusions of rabbit testes with 7~- 3 H-progesterone.-­
Results are expressed as percentage 3H of the total 7~- 3H-
3 progesterone used. H-17,20-P-values were not corrected for 
losses during the isolation procedure 
testis % 3H-l7,20-P % 3H-T 
1.5 4. 7 
2 1.0 2. 2 
3 1.6 8. 0 
4 2.4 IS 
5 0.8 B. 9 
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ne alone 
indicate 
reflect the activity of the c 17 , 20-lyase. The data 
that substantial amounts of 3H-17a,20a-dihydroxy-
4-pregnen-3-one were formed and secreted. 
1.3.3 Kinetics of C -lyase from rabbit testis 
17,20 
From the Lineweaver-Burk plot (fig. 4) it can be con-
cluded that the apparent Km-value ofthe rabbit c 17 , 20-lyase 
for 17a-hydroxyprogesterone is 5 f.!M. This value is in 
the same range as that for the rat testis enzyme (1.8 f.!M) 1 . 
At high substrate concentrations, when enzyme saturation 
should be obtained, the percentage conversion of the added 
radioactive 17a-hydroxyprogesterone decreased to such low 
values that the estimations became inaccurate. Therefore, 
the substrate concentrations were kept at 3-6 f.!M in most of 
the experiments and incubations were not performed under 
conditions of enzyme saturation. 
K =6 
m 
1/v 
10 
5 
0 0.1 0.2 0.3 -I 
1/S( ~M ) 
Fig. 4. Lineweaver-Burk plot of C17 20-lyase activity for the conversion of 170.-
hydroxyprogesterone to ondro~tenedione in a 800 - 105,000 x g pellet from 
rabbit testis. Velocity (v) is expressed as nmoles of androstenedione and testosterone 
formed per mg of protein per 30 minutes (2.0 mg of protein per incubation.) 
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1.3.4 Discussion and conclusions 
Androstenedione and testosterone are the main metabo-
lites formed from 17a-hydroxyprogesterone metabolism in rat 
and rabbit testes. The presence of Sa-reductase activity in 
rat testis was first described by Inano and Tamaoki 100 and 
by Nayfeh and Baggett101 and in 1972 by Folman et a1. 105 
One of the products in rabbit testis, the 3S-hydroxy-Sa-
androstan-17-one has 
. 100,104 testls . Payne 
previously only been reported in rat 
and Jaffe 109 obtained an indication 
for the formation of the 5a-androstane-3S,l7S-diol although 
good evidence for its identification was not given. 
Significant amounts of 3a-hydroxysteroids could not be 
detected after incubation with rabbit testis. Hydroxylation 
of androgens at the 7a-position112 was not detectable be-
cause this eliminates the tritium label from the steroid 
molecule. The rate of ?a-hydroxylation is in any case low 3 
The results also seem to indicate that the 2Da-hydroxy-
steroid dehydrogenase activity, relative to the c 17 , 20 -
lyase activity, is higher in rabbit than in rat testis, al-
though the lack of enzyme saturation with substrate prevents 
drawing definite conclusions. 
On basis of these experiments with labelled precursors 
it is concluded that 17a,20a-dihydroxy-4-pregnen-3-one is 
most probably formed under in vivo conditions. 
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1.4 Inhibition of C17•201yase 
1.4.1 Introduction 
The enzyme c 17 , 20-lyase has a key role in the conver-
sion of c 21-steroids to androgens. In rat testis this en-
zyme catalyses the rate-limiting step in the conversion of 
pregnenolone to testosterone133 . The activity of this en-
zyme may be regulated by 17a,20a-dihydroxy-4-pregnen-3-one, 
as postulated by Inane and coworkers 1 ' 2 (see paragraph 
1.1.2) and also by 20a(and S)-dihydroprogesterone1 ' 13 . ~ 
~ incubation experiments with subcellular fractions in-
dicate that 17a,20a-dihydroxy-4-pregnen-3-one but not 
20a(and s)-dihydroprogesterone are formed in this tissue. 
It was decided to investigate under several experimental 
conditions the inhibition of c 17 , 20-lyase. In addition to 
the incubation experi~ents, rabbit testes were perfused in 
order to study the possible effects of inhibitors on the 
steroid biosynthesis in the intact testis under more phy-
siological conditions. 
One of the inhibitors investigated was the new synthe-
tic steroid, 178-ureido-1,4-androstadien-3-one, which was 
selected by Arth et a1. 22 from a series of androstane deri-
vates as one of the best inhibitors for the c 17 , 20-lyase. 
These authors measured inhibition in terms of a decreased 
production of 14c-acetate obtained by side-chain cleavage 
14 
of 21- C-17~-hydroxyprogesterone. This inhibitor was fur-
ther characterized and also tested in rabbit testis. The 
rabbit testis probably provides a better model for compari-
son with human testicular testosterone biosynthesis than 
the rat testis because of the predominance of the ~ 5 ,38-
hydroxysteroid pathway (see paragraphs 2.1 and 2.3.3). 
56 
30 
20 
c 
.2 
0 
• > 
c 
0 
u 
"if'. 
10 
0 
----------------------
19 29 
control 17,,20-P 
70 
200--0H-P 
15 1~M 
76% inhibition 
29 ~-OH-P 
Fig. 5. Inhibition of C17 20-lyase activity by 170.,200.-dihydroxy-4-pregnen-3-one 
(17,20-P), 20 a.-clihydroprogesterone (20 a -OH-P) and 20 B -di hydroprogesterone 
(20~-0H-P) in a 800- 105,000 x g fraction from rabbit testis (1.8 mg of protein 
per incubation). 170'.-Hydroxyprogesterone (3 fJM) was used as a substrate. The vertical 
bars represent the sum of c17 20-lyase products, the percentages of inhibition ore 
given in the top of the figure'. Each value is the mean of duplicate estimations. The 
rate of conversion without inhibitors was 0.45 nmoles per mg of protein per 30 min. 
~ 3p -hydroxy-Sa -androstone-3-one D testosterone II androstenedione 
1.4.2 Incubation experiments 
A comparison was made between the effects of 20a(and 
S)-dihydroprogesterone and 17a,20a-dihydroxy-4-pregnen-3-
one in their ability to inhibit c 17 , 20-lyase activity in 
rabbit testis in vitro (fig. 5). The 20-reduced metabolites 
of progesterone were found to be the better inhibitors. 
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When these compounds were added, the sum of c 17 , 20 -lyase 
products decreased but the contribution of androstenedione 
to the products increased relatively to that of testostero-
ne and 3S-hydroxy-5~-androstan-17-one. The latter is in ac-
cordance with inhibition of the c17 , 20-lyase. 
From comparison of the results in fig. 5 with that of 
table 8 (see paragraph 1.3.2) it can be concluded that the 
concentration of 17a,20a-dihydroxy-4-pregnen-3-one, neces-
sary for inhibition (15 ~M), was much higher than the amount 
formed during incubation (0.7 ~M, from table 8) under compa-
rable experimental conditions. 
Investigation of the kinetic properties of the inhibi-
tion revealed that 20a-dihydroprogesterone is a competitive 
inhibitor with an apparent Ki-value of 2-5 ~M (fig. 6). The 
corresponding value for 17a,20a-dihydroxy-4-pregnen-3-one, 
also a competitive inhibitor, was 9 ~M1 . On the basis of 
1/v 
3 
2 
0 
K.=2-5 pM 
I 
20 
17-0H-P 
• 5 I'M 
• 
10 
40 
20 a-OH-P ( pM) 
Fig. 6. Inhibition of the C17 20-lyase by 20 0:-dihydroprogesterone (20a-OH-P) in 0 
washed 900 - 105,006 x g fraction of rat testis (1.3 mg of protein per 
incubation), represented in a Dixon type plat97. 170:-Hydroxyprogesterone (17-0H-P) 
was used as a substrate. The velocity is given as nmoles of androstenedione and 
testosterone formed per mg of protein per h. 
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Fig. 7. The effect of preincubation with inhibitor on the inhibition of c17 20-lyase in 
minced rat testis. Decapsulated, minced testis tissue (9.3 mg of profein per 
incubation) was preincubated with 20 CX.-dihydroprogesterone (20 o.-OH-P) or with 
17 ~-ureido-1,4-androstadien-3-one (17-UADO) for various time periods. !n control 
experiments the tissue was preincubated without inhibitor. The reactions were started 
by adding the substrate 7a-3H-l7a-hydroxyprogesterone (final concentration 5 pM). 
The rate of conversion in the control incubations was 0.18 nmoles of androstenedione 
and testosterone formed per mg of protein per h. 
these similarities we have also used 20a-dihydroprogestero-
ne as an inhibitor in the perfusion experiments. 
The next experiments were designed to find out if the 
inhibitors can enter rapidly into the testicular cells 
(fig. 7). If the inhibitor penetrated slowly when compared 
with the substrate 17a-hydroxyprogesterone, preincubation 
with inhibitor should result in a better inhibition. From 
fig. 7 it can be concluded that only for the 17S-ureido-
l,4-androstadien-3-one the rate of penetration does influ-
ence the degree of inhibition. 
Experiments were carried out to determine the influence 
of albumin on enzyme activity and inhibition (table 10). In 
solution albumin (4%) binds in the order of 90% of the com-
4 . 113 
man ~ ,3-oxosterolds and the (tenfold) decrease in free 
substrate and inhibitor concentrations may explain the de-
creased conversion found,as well as the less efficient in-
hibition by 20a-dihydroprogesterone (table 10). Billiar and 
59 
Little114 , 115 also observed that human albumin (2%) de-
creased the 2Qa-hydroxysteroid dehydrogenase activity of a 
placental enzyme preparation, but low concentrations (0.2%) 
increased the activity, apparently due to inactivation of 
a lipophilic,inhibiting substance. A recent paper from 
Hamilton et a1. 116 demonstrated the diversity and species 
differences in the action of several plasma proteins on 
steroid 21-hydroxylase, ~ 5 ,3S-hydroxysteroid dehydrogenase 
and ~ 5 .~ 4 -isomerase from adrenal origin. 
Table 10 EFFECT OF ALBUMIN ON THE c 17 , 20 -LYASE ACTIVITY AND THE 
INHIBITION BY 20a-DIHYDROPROGESTERONE (20a-OH-P) . 
Incubation with the 800-lOS,OOOxg fraction of rabbit testis 
(2.0 mg protein per incubation). Conversion of 7a- 3H-17a-hydroxy-
3 progesterone (4 wM) is expressed as the total percentage H pre-
sent in the c 17 , 20-lyase products. The control rate of conver-
sion (without albumin) was 1.5 nmoles per mg of protein per 
30 min 
bovine serum 
albumin added 
4% 
60 
% 3a <n C 1 d ~ 17 , 20- yase pro ucts 
control 
48 
47 
31 
30 
20a-OH-P (10 wM) 
23 
25 
25 
25 
% inhibition by 
20a-OH-P 
49 
17 
1.4.3 Perfusion experiments with rabbit testis 
Continuous infusion with tracer amounts of 3a-labelled 
progesterone was carried out and the incorporation of label 
into the c17 , 20-lyase products was estimated. This in order 
to determine whether or not an infused inhibitor had a spe-
cific effect on the c17 , 20-lyase activity when infused over 
a certain period. As mentioned before (paragraph 1.3.2) the 
amount of 3H-testosterone secreted was about five to ten 
times more than that of the 3a-androstenedione, thus the 
values for 3H-testosterone alone are given. The tritium 
incorporation is expressed as a percentage of the total 
tritium in the venous blood sample, this in order to cor-
rect for possible small fluctuations in the flow rate and 
the infusion rate of labelled progesterone. 
During infusion through the testis labelled progestero-
ne was converted to 17a-hydroxyprogesterone, the latter 
being the actual substrate for the c 17 , 20-lyase. An equili-
brium with the endogenous steroid production was apparently 
reached after two hours perfusion because the secreted tes-
tosterone had a constant specific activity after this time 
(fig. 8). Therefore, in subsequent experiments the potential 
inhibitors were infused after two hours perfusion. The final 
concentration of the inhibitor in the perfusion medium du-
ring the period of infusion was in the order of 10 ~M (ex-
cept for the third perfusion). Inhibition would result in 
decreased 3H-testosterone secretion and might enhance the 
3 H-17a-hydroxyprogesterone secretion. 
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From fig. 9 it can be concluded that 17a,20a-dihydroxy-
4-pregnen-3-one did not influence the 3H-incorporation into 
testosterone at the time of infusion or later. During the 
second perfusion 4- 14c labelled inhibitor was infused and 
the larger part of it appeared immediately into the venous 
blood, only 0.6% (uncorrected) of the inhibitor could be 
extracted from the testis tissue (fig. 10). In perfusion 
number 3 the same amount of 17a,20a-dihydroxy-4-pregnen-3-
one was administered over a longer period, apparently also 
without effect. 
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Fig, 9, 3H-Testosterone, isolated from the testicular venous ~load after in vitro 
perfusion of rabbit testis with 7a.-3 H-progesterone. H-Testosterone values are 
expressed as percentage of the total amount of tritium in the venous blood samples. 
Perfusion 1: 90 nmoles of 170.,200.-dihydroxy-4-pregnen-3-one (17,20-P) were infused 
over a 20 min period after perfusion for 2~ h" 
Perfusion 2; as 1, in this case 4- 14c-labelled inhibitor has been used. 
Perfusion 3: 90 nmoles of the inhibitor 17,20-P were infused over a two hour period, 
starting at 2:1 h. 
Fig. 10. 4- 14 C- 17 0.,20 a -Di hydroxy-4-pregnen-3-one, isolated from the testicular venous 
blood of gerfusion 2 (fig. 9). The values are expressed as percentage af the 
total amount of 1 C-inhibitor which was infused and these values were not corrected for 
losses incurred to the isolated procedure" At the end of the experiment, 0.6% of the 
14C-inhibitor could be isolated from the testis. 
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Fig. 11. 3H-Incorporation into testosterone, isolated from the testicular venous blood 
3 after in vitro perfusion of rabbit testis with 17d.-3H-progesterone. H-Testosterone values are given as percentage of the total amount of tritium in the 
venous blood samples. 
Perfusion 4: control experiment, no inhibitor was infused. 
Perfusion 5 and 6: 65 nmoles of 20 CX.-dihydroprogesterone (20 d.-OH-P) were infused 
over a 20 min period, starting at 2i h and 2 h respectively 
(indicated by arrow). 
Perfusion experiments using the 20a-dihydro-
progesterone, a better inhibitor in incubation experiments, 
also had no effect on the 3H-testosterone secretion (fig. 
11). From the perfusate collected at the time of inhibitor 
infusion, sufficient 20a-dihydroprogesterone could be iso-
lated to cause an ultra-violet light absorbing zone on the 
paper strip after Bush AII paper chromatography, an indica-
tion for at least a 30-40 nmoles of steroid. Thus, .absence 
of inhibition cannot be explained by metabolism of the in-
hibitors. 
The testosterone secretion, estimated in the same expe-
riments, did not change during the infusion of inhibitors. 
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1.4.4 Inhibition of C -lyase by 17~-ureido-1,4-androstadien-3-one 
17,20 
178-Ureido-1,4-androstadien-3-one was found to be a 
competitive inhibitor with a high affinity for the rat tes-
tis c17 , 20-lyase (apparent K1-value in the range of Q.l-0.3 
~M, fig. 12) From fig. 13 it is not clear if this steroid 
inhibited the conversion of labelled 17a-hydroxyprogeste-
rone to testosterone, when it was infused during rabbit 
testis perfusions (final concentration in the perfusion 
medi urn 2-3 llM) . 
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Fig. 12, Inhibition of c 17 20-lyase activity by 17 ~-ureido-1,4-androstodien-3-one (17-UADO) in a 'washed 900 - 105,000 x g fraction of rat testis (1.3 mg of 
protein per incubation), represented in a Dixon type plot97_ 
170.-Hydroxyprogesterone (17-01-1-P) was used as a substrate. The velocity is given as 
nmoles of androstenedione and testosterone formed per mg of protein per h. 
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Fig. 13. H-Testosterone, isolated from the testicular venous effluent after in vitro 
perfusion of rabbit testis with 7a:.-3 H-progesterone. The testis was perfused 
with rabbit erythrocytes (30%, by val.), suspended in Krebs-Ringer bicarbonate buffer 
(pH 7,4), containing 4% of bovine serum olbumine. 3H-Testosterone values are given 
as percentage of the total amount of tritium in the venous effluent samples. 
Perfusion 7 and 8: 20 nmoles of 17 p-ureido-1,4-androstadien-3-one (17-UADO) were 
infused over a 20 min period, starting at 2 h as indicaTed by the 
arrow .. 
Goldman demonstrated that administration of steroid 
isoxazole, an inhibitor with a high affinity for the 38-
hydroxysteroid dehydrogenase, leads to accumulation of 
this inhibitor in the adrenal and ovary of female rats 77 
The higher incorporation of progesterone label into testos-
terone in this perfusion experiment (fig. 13), when compared 
with previous experiments (fig. 9 and 11), was probably 
caused by the absence of "corticosteroid binding globulin" 
in the perfusion medium. 
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Table 11 COMPARISON OF THE INHIBITION OF c 17 , 20 -LYASE ACTIVITY 
BY 176-UREID0-1,4-ANDROSTADIEN-3-0NE {17-UADO) IN RAT 
AND RABBIT TESTIS. 
3 7~- H-17a-Hydroxyprogesterone (5 ~M) was incubated with the 900-
105,000xg fractions of rat and rabbit testis (1.3 and 2.1 mg of 
protein 
tage of 
version 
respectively). Conversions are given as the total percen-
3 . H 1n the c 17 , 20-lyase products. The control rates of con-
were 1.4 and 0.9 nmoles per mg of protein per 30 min 
E S · % 3H <n C l d xp. pec1es ~ 17 , 20 - yase pro ucts 
rat 
2 rabbit 
control 17-UADO 17-UADO 
47 
49 
31 
30 
0.6 ~M 
18 
21 
9.0 ~M 
24 
22 
% inhibition 
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23 
A comparison between the rat and rabbit testis revea-
led that a much higher concentration of the l?S-ureido-1,4-
androstadien-3-one was necessary for inhibition of the rab-
bit testis lyase (table 11). This less efficient inhibition 
can be explained by species differences in the properties 
of the c17 , 20-lyase but might also be indicative of the 
presence of two lyases, one specific for 17a-hydroxyproges-
terone and one for the l7a-hydroxypregnenolone (the latter 
being found predominantly in rabbit testis). 
It is therefore desirable that the screening procedure 
for specific inhibitors of human testosterone production 
should include various animal species. 
67 
1.4.5 Conclusions and discussion 
It is concluded that during in vitro incubation 17a, 
20a-dihydroxy-4-pregnen-3-one and 20a-dihydroprogesterone 
can inhibit the c17 , 20-lyase activity of both rat and rab-
bit testis. 20a-Dihydroprogesterone is a competitive inhi-
bitor of the rat testis enzyme (apparent Ki = 2-5 ~M). 
These potential inhibitors, added to the arterial blood in 
concentrations of 10 ~M, do not inhibit the c 17 , 20-lyase 
in perfused rabbit testis. 
The presence of albumin can partial-ly mask the inhibi-
tory effects. Therefore in vitro incubations with dilute 
subcellular fractions in the absence of albumin may lead to 
a high degree of inhibition. On the other hand, in total 
tissue extracts or in the intact cell inhibitions might be 
less effective because of the presence of relatively high 
concentrations of cytosolic proteins. 
The absence of inhibition during the perfusion experi-
ments might also result from a poor penetration of 20a-
dihydroprogesterone and 17a,20a-dihydroxyprogesterone into 
the tissue. However the following arguments make this ex-
planation difficult to accept: 
a. 20a-dihydroprogesterone apparently did enter rapidly into 
minced rat testis tissue during incubation experiments 
(fig. 7). 
b. the concentration of inhibitor in the perfusion medium 
(approximately 10 uM) was much larger than the progeste-
rone concentration (1-3 nM), while only an inhibitor 
concentration three times as high as the substrate con-
centration was necessary for inhibition during incuba-
tion experiments with homogenate fractions. 
c. Also after perfusion of both 3H-progesterone and 14c-
17a,20a-dihydroxy-4-pregnen-3-one (fig. 9), both isotopes 
were present in the inhibitor isolated from the venous 
blood and testis tissue. 
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calculations, according to Gurpide 117 of the uptake 
of inhibitor by the tissue unfortunately cannot be applied 
because this requires a continuous infusion of labelled 
inhibitor and steady state conditions. Therefore the amount 
of 17a,20a-dihydroxy-4-pregnen-3-one which had penetrated 
into the tissue remained unknown. Finally it must be kept 
in mind, that in the in vivo situation the 17a,20a-
dihydroxy-4-pregnen-3-one is synthesized at the subcellular 
level, whereas in the perfusion experiments this compound 
was added to the arterial blood. 
From the results of these perfusion experiments it 
cannot be concluded if 17a,20a-dihydroxy-4-pregnen-3-one 
is of importance for the regulation of testosterone biosyn-
thesis in vivo. 
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1. 5 Estimation of 17a,20a-dihydroxy-4-pregnen-3-one 1n 
testis tissue 
1.5 .1 Introduction 
The evaluatiori of the role of 17a,20a-dihydroxy-4-
pregnen-3-one as inhibitor of c 17 , 20-lyase made it necessa-
ry to develop a method for its estimation and determination 
in testis tissue. A comparison of the levels of l7a,20a-
dihydroxy-4-pregnen-3-one with those of 17a-hydroxyproges-
terone in testis tissue should reveal if enough inhibitor 
is present to compete with the substrate for the c17 , 20 -
lyase. 
The estimation method has been described in detail in 
paragraph 1.2.8. Table 12 gives the mean recoveries of 
17a,20a-dihydroxy-4-pregnen-3-one at several stages of the 
estimation. 
Table 12 RECOVERIES DURING ESTIMATION OF 300 PMOLES 
l7a,20a-DIHYDROXY-4-PREGNEN-3-0NE 
The recovery is expressed as per cent tritium of the added 
internal standard. The mean of ten estimations and S.D. 
are given. 
Mean recovery after 
1. Periodic acid oxidation and t.l.c. 
2. NaBH 4-reduction of androstenedione 
and t.l.c. 
3. Chloroacetylation of testosterone 
and t.l.c. 
70 
% tritium 
58 + l3 
39 + ll 
20 + 8 
Table 13 ACCURACY AND PRECISION OF THE ESTIMATION OF 
l7a,20a-DIHYDROXY-4-PREGNEN-3-0NE 
Added Estimated S.D. S.D. 
(pmoles) (pmoles) (pmoles) (%) n 
300 322 51 16 12 
75 90 17 19 6 
The accuracy and reproducibility of the method were 
calculated from a series of determinations of known amounts 
of 17~,20~-dihydroxy-4-pregnen-3-one added to a 0.9% NaCl 
solution, containing 1% of bovine serum albumin (table 13). 
Estimations of "blank samples" without steroid gave 
results in the order of 1 to 5 pmoles of testosterone chlo-
roacetate. After corrections for losses that occurred during 
the isolation procedure, an average blank value in the order 
of 15 pmoles was obtained. All the values given for 17~,20~­
dihydroxy-4-pregnen-3-one, have been corrected for the mean 
blank value of the particular series of determinations. The 
sensitivity of the method is approximately 15 pmoles. 
1.5.2 Concentrations of 17a-20a-dihydroxy-4-pregnen-3-one 
The concentrations were estimated in testes of six 
rats and compared with the 17a-hydroxyprogesterone concen-
trations as measured .by a competitive protein binding assay 
(see paragraph 1.2.7). The amounts of 17a,20a-dihydroxy-4-
pregnen-3-one in testis tissue were small and often below 
the limits of detection. 
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Table 14 CONCENTRATIONS OF 17,-HYDROXYPROGESTERONE 
(l70H-P) AND l7a,20,-DIHYDROXY-4-PREGNEN-3-0NE 
(17,20-P) IN RAT TESTIS 
The testes of each rat were assayed together (2.5-3 g wet 
weight), the values for 170H-P are the mean of triplicate 
estimations. 
rat 
l 
2 
3 
4 
5 
6 
mean ~ S.D. 
l70H-P 
(pmoles/g) 
7 
24 
55 
88 
100 
33 
51 
.:!: 38 
17,20-P 
(pmoles/ g) 
<5 
<5 
10 
<5 
20 
13 
( 10) 
It is evident from the results in table 14, however, 
that the levels of this potential inhibitor are at least a 
five times lower than those of 17a-hydroxyprogesterone. The 
concentrations of this steroid in rabbit testis (6-7 g each 
pair) were equally low and almost undetectable. It was not 
possible to detect significant amounts of 17a,2Da-dihydroxy-
4-pregnen-3-one in 20 minutes samples of testicular venous 
blood of rats and rabbits. 
1.5.3 Discussion and conclusions 
The specificity of the estimation of 17a,20a-dihydroxy-
4-pregnen-3-one is guaranteed by the combination of the 
chemical conversions with chromatographic purifications. 
Androstenedione and testosterone, both present in the sam-
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ples, were separated from the 17a,20a-dihydroxy-4-pregnen-
3-one at the first chromatographic step. When 14c-labelled 
testosterone was added to the samples, no 14c-radioactivity 
was detectable in the purified fractions. Pregnane metabo-
lites with a 178,20-dihydroxy structure, if present, might 
have been converted to 5a(S)-androstane-3,17-dione 118 and 
subsequently to 176-hydroxy-Sa(B)-androstane-3-one chloro-
acetate, but the latter compound separates from testoste-
rone chloroacetate during gas chromatography on a QF-1 
column. The 208-isomer of the inhibitor has a higher Rf-
value after paper chromatography than the 20a-isomer. More-
over, the 208-hydroxysteroid dehydrogenase activity is rela-
tively low119 and it is unlikely that the 206-isomer can 
interfere. 
The low recovery obtained after the isolation and puri-
fication procedure is compensated by the high sensitivity 
of the electron capture detection. A possibility for a more 
practical estimation method might be the gas chromatography 
of 17a,20a-dihydroxy-4-pregnen-3-one as the trimethylsilyl-
ether. This latter possibility has been applied to the es-
timation of pregnanetriols 120 This approach for our esti-
mation might have resulted in higher recoveries, but the 
lower sensitivity of flame-ionization detection makes it 
doubtful whether such a method would be more sensitive. 
The amounts of 17a,20a-dihydroxy-4-pregnen-3-one in rat 
testis tissue are low and only two or three times higher 
than the blank values. Moreover, one might expect that the 
method will lack specificity at these low levels and there-
fore the actual levels may be even lower than the estimated 
levels. Hence, it is concluded that the presence of endoge-
nous 17a,20a-dihydroxy-4-pregnen-3-one in testis tissue is 
not certain and that, if present, its level is at least 
five times lower than the level of 17a-hydroxyprogesterone. 
Further consequences are discussed in paragraph 1.7.1. 
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1.6 Localization of 2011{-hydroxysteroid dehydrogenase 
in rat testis 
1.6.1 Introduction 
Testosterone is produced in the Leydig cells of the 
interstitial tissue~ 9 For the evaluation of the role of 
17a,20a-dihydroxy-4-pregnen-3-one it is relevant to know if 
the 20a-hydroxysteroid dehydrogenase is preferentially loca-
lized in interstitial tissue or seminiferous tubules. 
Fevold and Eik-Nes 121 determined the levels of several 
enzymes in the testis tissue from Passer dornesticus in dif-
ferent stages of their annual testicular cycle. The relati-
vely low 20a-hydroxysteroid dehydrogenase activity in tes-
tis with regressed spermatogenesis suggested that this en-
zyme was located in the germinal epithelium. Other observa-
tions indicate, however, that the situation in rat testis 
is more complex. The specific activity of the 20a-hydroxy-
steroid dehydrogenase in immature rat testis is comparable 
to the activity in adult rats 100 , Testes subjected to X-ray 
treatment 122 or experimental cryptorchidism123 showed high 
activities and exposure of rats to a hot environment also 
resulted in a small increase in the l7a,20a-dihydroxy-4-
pregnen-3-one formation in vitro1241125 . These treatments 
result in a destruction of the germinal cells and therefore 
localization of the enzyme in the germinal cells is not 
likely. However 1 the Sertoli cells and the intersti.tium, 
which are not affected by these treatments, may be consi-
dered to contain 20a-hydroxysteroid dehydrogenase. The en-
zyme activity in rat testis was not increased by HCG treat-
ment in vivo 126 , 127 . Baillie128 cited unpublished work con-
cerning the histochemical detection of 20a-hydroxysteroid 
dehydrogenase activity in the human Leydig cells. 
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Following the demonstration that interstitial tissue 
and seminiferous tubules from rat testis can be separated 
with a simple dissection technique, it is now possible to 
study directly the steroid biosynthesis and metabolism in 
these isolated structures129 , 130 . Lacy et a1. 131 , 132 des-
cribed the formation of 20a-dihydroprogesterone from pro-
gesterone and pregnenolone by isolated seminiferous tubu-
les of rat testis in vitro, although comparison on a quan-
titative basis with the interstitial tissue was not made. 
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Fig. 14. localization of 20 CX.-hydroxysteroid dehydrogenase in rot testis. Phenyl esterase 
activity was determined in sonicated samples of total homogenotes of the 
tissues, using p-nitrophenylacetate as a substrate. The 20 0. -hydroxysteroid dehydrogenase 
activity was estimated in the 105,000 x g supernatants with 170:.-hydroxyprogesterone 
(30 tJM) as a substrate, the specific activities in seminiferous tubules and interstitial 
tissue were respectively 39 and 8.4 pmoles per mg of protein per minute. 
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1.6.2 Results and discussion 
The activities of the 20a-hydroxysteroid dehydrogenase 
were estimated in the soluble fractions from dissected se-
miniferous tubules and interstitial tissue from rat testis, 
using 17a-hydroxyprogesterone as a substrate (fig. 14). A 
non-specific phenyl esterase, localized in the interstitial 
tissue was used as an enzyme rnarker 95 . The separation fac-
tor between tubules and interstitium was 50 or better. 
From the results in fig. 14 it is evident that the 
20a-hydroxysteroid dehydrogenase is mainly localized in the 
seminiferous tubules. Some conversion can occur in the in-
terstitium and it cannot be excluded that this enzyme acti-
vity reflected contamination with tubular material, because 
a marker enzyme for seminiferous tubules was not determined. 
Calculation of enzyme activity per gram of total testis 
shows that 97% of the enzyme is of tubular origin. Hence, 
if sufficient substrate is available, most of the 17a,20a-
dihydroxy-4-pregnen-3-one will be produced in the tubules, 
and not at the site of testosterone formation in the Leydig 
cells. The 20a-hydroxysteroid dehydrogenase activity does 
not correlate with the development of the germinal 
cellslOO,l 22 - 125 and therefore a localization in the Sertoli 
cells may be postulated. 
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1.7 Conclusions and general discussion 
1.7.1 Conclusions 
It appears from the results in paragraph 1.4, that the 
presence of endogenous 17a,20a-dihydroxy-4-pregnen-3-one in 
testis tissue from rats and rabbits is doubtful. In rat tes-
tis the levels of l7a,20a-dihydroxy-4-pregnen-3-one are at 
least five times lower than levels of 17a-hydroxyprogeste-
rone. These low tissue levels render the possibilities for 
inhibition unfavourable, because it is known from the enzyme 
kinetic studies 1 , that the apparent Km-value of the c 17 , 20 -
lyase for 17a-hydroxyprogesterone is 2 ~M, whereas the appa-
rent Ki-value for 17a,20a-dihydroxy-4-pregnen-3-one is 9 ~M. 
This reflects that the enzyme has a greater affinity for the 
substrate than for the inhibitor. Thus, as found in the in-
cubation experiments (see paragraph 1.4.2), inhibitor con-
centrations higher than the substrate concentrations are 
required for effective inhibition. The results of estima-
tions of 17a,20a-dihydroxy-4-pregnen-3-one indicate, how-
ever, that the opposite situation is actually found in the 
rat testis. Concentrations of 17a,20a-dihydroxy-4-pregnen-
3-one are lower than 0.01 wM, whereas the concentration of 
17a-hydroxyprogesterone is in the order of 0.05 wM. More-
over, 97% of the 20a-hydroxysteroid dehydrogenase activity 
of the rat testis is localized in the seminiferous tubules 
and the endogenous 17a,20a-dihydroxy-4-pregnen-3-one, if 
any, may not be produced at the site of the testosterone 
production. 
It is concluded therefore that the 17a,20a-dihydroxy-
4-pregnen-3-one has no function in the regulation of the 
c17 , 20-lyase activity and testosterone production in the 
Leydig cells in vivo. 
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1.7.2 Subcellular distribution of steroids, 
binding to the endoplasmatic reticulum 
49 134 135 Matsumoto and Samuels ' ' found that, during in-
cubation Of progesterone and 17a-hydroxyprogesterone with a 
microsomal preparation of mouse testis, the incorporation 
of the progesterone label into androstenedione and testoste-
rone was approximately two times higher than the incorpora-
tion of the 17a-hydroxyprogesterone label. When they tried 
to explain this result they observed that progesterone binds 
better to the microsomal particle than 17a-hydroxyprogeste-
rone and this difference in binding could account for the 
isotope ratio in the products. Similar results have been 
obtained for rat and rabbit testes 136 . Burstein and Gut 137 
interpreted these results by proposing a specific spatial 
arrangement of the enzymes on the microsomal surface, which 
can cause a direct transfer of the newly formed 17a-hydroxy-
progesterone to the cl7,20-lyase 
intermediate into the medium. As 
without release of this 
a result, a free exchange 
between added and endogenously formed 17a-hydroxyprogeste-
rone is hampered. If this theory is correct another argument 
is obtained for the inability of 17a,20a-dihydroxy-4-pregnen-
3-one (either added exogenously or transported endogenously 
from the seminiferous tubules) to compete with c 17 , 20-lyase 
for the locally formed 17a-hydroxyprogesterone. 
When interpreting the mean tissue concentration (see 
paragraph 1.7.1) an ever recurring point for discussion is 
the possibility for a locally high substrate concentration 
on or in the subcellular organella. From the foregoing dis-
cussion, it is clear that the formed 17a-hydroxyprogesterone, 
rather than the 17a,20a-dihydroxy-4-pregnen-3-one, is much 
more likely to concentrate on the endoplasmatic reticulum. 
This may support the conclusion from paragraph 1.7.1. 
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1.7.3 Localization of 20a-hydroxysteroid dehydrogenase: 
further consequences 
3H-Labelled l7a,20a-dihydroxy-4-pregnen-3-one was se-
creted during the perfusion experiments with 3H-progeste-
rone (see paragraph 1.3.2), but the rabbit testis in situ 
did not secrete detectable amounts of endogenously formed 
17a,20a-dihydroxy-4-pregnen-3-one (see paragraph 1.5.2). 
This apparent discrepancy may be explained by the access of 
the substrate to the lyase and by the location of 20a-hydro-
xysteroid dehydrogenase activity. One can assume that during 
the perfusion experiments 3H-progesterone also penetrates 
the seminiferous tubules, as has 
ral steroids138- 141 . In addition 
!?a-hydroxylase activity129 , 130 , 
been demonstrated for seve-
these tubules also contain 
3 
so that H-17a,20a-
dihydroxy-4-pregnen-3-one can be formed and secreted. The 
cholesterol side-chain cleaving enzyme is not active in the 
seminiferous tubules 130 ' 142 and in vivo the essential sub-
strates will primarily be available in the Leydig cells. 
Apparently the seminiferous tubules either do not utilize 
17a-hydroxyprogesterone from the Leydig cells for 20a-
reduction or the product is rapidly metabolized. The testi-
cular 3a-hydroxysteroid dehydrogenase and Sa-reductase acti-
vities may be preferentially located in the seminiferous 
tubules 108 , 132 and at least this Sa-reductase can also re-
duce c21 -steroids
143
. Therefore, accumulation of 17a,20a-
dihydroxy-4-pregnen-3-one may also be prevented by further 
metabolism. 
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1.7.4 The possible function of 20a-hydroxysteroid dehydrogenase 
A possible function of the 20a-hydroxysteroid dehydro-
genase in testis may be the elimination of 17a-hydroxypro-
gesterone as a precursor for testosterone rather than the 
production of an inhibitor for the c 17 , 20-lyase. A similar 
function has been proposed for the testicular 5a-reduc-
tase103,106. Increasing ovarian 20a-hydroxysteroid dehydro-
genase activity is a sensitive index for luteolysis in rat 
and rabbit ovaries and causes a fall in progesterone secre-
tion and a concomittant rise in the 20a-dihydroprogesterone 
secretion145 . The cessation of progesterone secretion by 
the rat ovary, which precedes parturation and lactogenesis 
at the end of the pregnancy, is primarily the consequence 
of the sharp increase in 20a-hydroxysteroid dehydrogenase 
activity146 r 147 . Both examples illustrate the inactivation 
of progesterone by conversion to a metabolite with hardly 
any progestational activity. A possible function of 17a-
hydroxyprogesterone metabolism in the seminiferous tubules 
of testis, however, is unknown. 
80 
1. 8 References 
1 Inano,H., Nakano,H., Shikita,M. and Tamaoki,B. (1967) 
Biochim.Biophys.Acta 137,540-548 
2 Shikita,M., Inano,H. and Tamaoki,B. (1967)Biochemistry ~, 
1760-1764 
3 Inano,H. and Tamaoki,B. (197l)Biochim.Biophys.Acta ~,482-493 
4 Notation,A.D. and Ungar,F. (1968)Can.J.Biochem. !£.1185-1190 
5 Notation,A.D. and Ungar,F. (1969)Steroids .!,i,!Sl-159 
6 Notation,A.D. and Ungar,F. (1969)Biochemistry ~,501-506 
7 Payne,A.H., Mason,M. and Jaffe,R.B. (1969)Steroids l_i,685-704 
8 Payne,A.H. (1972)Biochim.Biophys.Acta ~,473-483 
9 Wiener,M. and Allen,S.H.G. (1967)Steroids !,567-582 
10 Wiener,M. and Allen,S.H.G. {l968)Steroids _!1.,261-273 
11 Jensen,V., Carson,P. and Deshpande,N. (1971)J.Endocrinol. ~~ 
177-178 
12 Jensen,V. 1 Carson 1P. and Deshpande,N. (1972)J.Endocrinol. 22~ 
311-321 
13 Neher 1R. and Kahnt 1F.W. (1965)Experientia ~ 1 310-312 
14 Kaartinen1E. I Laukkanen 1M. and Saure 1A. (197l)Acta Endocrinol. 
.§.§.I 50-64 
15 BurrowiG.N. 1 Mulrow,P.J. and Bondy 1P.K. (1966)Endocrinology 21~ 
955-963 
16 MorrOW 1 L.B. 1 Burrow 1G.N. and Mulrow,P.J. {l967)Endocrinology 
!l_(l_, 883-888 
17 Burrow,G.N. (1969)Endocrinology ~ 1 979-985 
18 Weinstein,R.L. and Kliman~B. (1972)Metabolism ll 1 99-106 
19 Sauer,L.A. (1972)Arch.Biochem.Biophys. 149,42-51 
20 Axelrod 1L.R. (1965)Biochim.Biophys.Acta ~,551 
21 Yanaihara,T. and Troen,P. (1972)J.Clin.Endocrinol.Metab. }i,783 
22 Arth,G.E., Patchett,A.A., Jefopoulos 1 T., Bugianesi,R.L., 
Peterson 1L.H., Hamm,E.A., Kuehl,F.A. and Brink,N.G. (1971) 
J.Med.Chem. l±,675-681 
23 Haksar,A., Romanoff,E.B., Hagino,N. and Pincus,G. (1967) 
Steroids 2,405-414 
24 Haksar,A. and Romanoff1E.B. (1968)Steroids ..!1_,345-357 
81 
25 Cook,B., Niswender,G.D., Sutterlin,N.S., Norton,H.W. and 
Nalbandov,A.V. (1968)Steroids l.!.,321-336 
26 Hall,P.F. {1970)in "The Testis''(Johnson,A.D., Gomes,W.R. and 
VanDemark,N.L. ,eds) ,Vol.2, p.lO,Academic Press,New York 
27 Dexter,R.~J., Fishman,L.M. and Ney,R.L. (l970)Endocrino1ogy ~~ 
836-846 
28 Ichii,S., Forchielli,E. and Dorfman,R.I. (l963)Steroids l• 
631-656 
29 Dorfman,R.F., Sharffia,D., Menon,K.M.J. and Forchielli,E. {1967) 
Proc. Third Asia and Oceania Congr. Endocrinology, pp.171-177, 
Manilla 
30 Koritz,S.B. and Hall,P.F. (1964)Biochemistry },1298-1304 
31 Koritz,S.B. and Kumar,A.M. (1970)J.Biol.Chem. ~,152-159 
32 Farese,R.V. (1971)Endocrinology ~,958-962 
33 Simpson,E.R., Jeffcoate,C.R., Brownie,A.C. and Boyd,G.S. (1972) 
Eur.J.Biochem. ~,442-450 
34 Menon,K.M.J., Drosdowsky,M., Dorfman,R.I. and Forchielli,E. 
(1965)Steroids,Suppl.I,95-111 
35 Co1by,H.D. and Kitay,J.I. (1972)Steroids l.Q.,143-151 
36 Brownie,A.C., Colby,H.O., Gallant,S. and Skelton,R.S. (1970) 
Endocrinology 86,1085-1092 
37 P€ron,F.G., Moncloa,F. and Dorfman,R.I. {1960)Endocrinology £2, 
379-388 
38 Birmingham,M.K. and Kurlents,E. (1958)Endocrinology 62,47-60 
39 Jensen,P.K. (l959)Nature(London) ..!:...§._!,451-452 
40 Stoppani,A.O.M., de Brignone,C.M.C. and Brignone,J.A. {1968) 
Arch.Biochem.Biophys. ~,463-475 
41 Sharma, D.C., Forchielli,E. and Dorfman,R.I. (l963)J.Biol.Chem. 
22§_,572-575 
42 Colby,H.D. and Brownie,A.C. (197l)Biochem.Pharmacol. l.Q.,803-813 
43 Brownie,A.C., Colby,H.D. and Simpson,E.R. (1971)in Proc. Third 
Int. Congr. Hormonal Steroids(James,V.H.T. and Martini,L.eds) 
pp.285-289,Excerpta Medica Foundation,Amsterdam 
44 Kitay,J.F. (1968)in ''Functions of the Adrenal Cortex'' 
(McKerns,K.W.)Vo1.2, p.786,North Holland Publishing Company, 
Amsterdam 
45 Sharma,o.c. and Dorfman, R.I. (l964)Biochemistry },1093-1097 
82 
46 Nayfeh,S.N. and Baggett, B. (1969)Steroids 1±,269-283 
47 Huseby,R.A., Dominguez,O.V. and Samuels,L.T. (1961) 
Rec.Progr.Hormone Res. !2,1-42 
48 Mahajan,D.K. and Samuels,L.T. (1962)Fed.Proc. 2!,209 
49 Samuels,L.T., Matusumoto,K., Aoshima,Y. and Bedrak,E. (1969) 
in ''Progress in Endocrinology'' (Gual,C. ed) ,pp.845-850, 
Excerpta Medica Foundation,Amsterdam 
50 Deshpande,N., Jensen,v., Carson,P., Bulbrook,R.D. and 
Doouss,T.W. (1970)J.Endocrinol. !2,231-242 
51 Eik-Nes,K.B. (1970)in ''The Androgens of the Testis'' 
(Eik-Nes,K.B. ,ed) ,p.22,Marcel Dekker,New York 
s: Goldman,A.S. (1967)J.Clin.Endocrinol.Metab. ~,320-324 
53 Patwardhan,V.V. and Lanthier,A. (1970)in Abstr. Third Int. 
Congr. Hormonal Steroids, Int. Congr. Series 210, p.110, 
Excerpta Medica Foundation,Amsterdam 
54 Kowal,J., Forchielli, E. and Dorfman,R.I. (1964)Steroids !• 
77-100 
55 Yanaihara,T., Troen,P., Troen,B.R. and Troen,M.L. (1972) 
J.Clin.Endocrinol.Metab. }i,968-973 
56 Krllskemper,H.L., Forchielli,E. and Ringold,H.J. (1964) 
Steroids 1,295-309 
57 Ewald,W., Werbin,H. and Chaikoff,I.L. (1964)Biochim.Biophys. 
Acta ~,199 
58 Ewald,W. and Weber,K.M. (l969)Acta Endocrinol.Suppl. ~,51 
59 Milgrom,E. and Beaulieu, E. E. (l970)Steroids ~,563-588 
60 Mousseron-Canet,M., Borgna,J.L., Beziat,Y. and Chavis,C. 
(l968)C.R.Acad.Sci.Paris ~,797-800 
61 Purdy,R.H., Malla,M. and Little,B. (1964)Biochim.Biophys.Acta 
~,557-560 
62 Ruokonen,A., Laatikainen,T., Laitinen,E.A. and Vihko,R. 
(1972)Biochemistry ll,l411-1416 
63 Garren,L.D., Hill,G.N., Masui,H. and Walton,G.M. (1971) 
Rec.Progr.Hormone Res. ~,433-474 
64 Koritz,S.B., Yun,J. and Ferguson,J.J. (l968)Endocrinology ~. 
620-622 
65 McCune,R.W., Roberts,S. and Young,P.L. (1970)J.Biol.Chem. 245 
3859-3867 
83 
66 Berger,G.M.B. and Jones,J.D. (1971)Endocrinology §....2_,722-729 
67 Sulimovici,S. and Boyd,G.S. (1969)Eur.J.Biochem. 2,549-558 
68 Sulimovici,S. (1970)in Abstr. Third Int. Congr. Hormonal 
Steroids, Int. Congr. Series llQ, p.117,Excerpta Medica 
Fou~dation,Amsterdam 
69 Kinson,G.A. (1971)Fed.Proc. lQ,Abstract 1568 
70 Ellis,L.C. (1972)Endocrinology 90,17-28 
71 Neville,A.M. and Engel,L.L. (l968)J.Clin.Endocrinol.Metab. ~. 
49-60 
72 Goldman,A.S. (1968)J.Clin.Endocrinol.Metah. ~,1539-1546 
73 Farese,R.V. (1970)Steroids J2.,245-250 
74 Goldman,A.S. (1970)Endocrinology ~,583-589 
75 Goldman ,A. S. ( 1969) Endocrinology ~. 325-329 
76 Bloch,£., Lew,M. and Klein,M. (197l)Endocrinology .§.2_,16-31 
77 Goldman,A.S. (l970)Endocrinology ~,678-686 
78 Lipner,H. and Greep,R.O. (1971)Endocrinology ~,602-607 
79 Gaunt,R., Steinetz,B.G. and Chart,J.J. (1968)Clin.Pharmacol. 
Ther. 2_,657-681 
80 Dorfman,R.I. and Ungar,F. (l965lin "Metabolism of Steroid 
Hormones", p.l35 and p.l81,Academic Press,New York 
81 Tamaoki,B. and Shikita,M. (1966)in ''Steroid Dynamics''(Pincus,G., 
Nakano,T. and Tait,J.F.,eds) ,pp.515-518,Academic Press,New York 
82 Inano,H., Inano,A. and Tamaoki,B. (1970)J.Steroid Biochem. !• 
83-91 
83 Goldman,A.S. (l971)Endocrinology ~,527-531 
84 Bray,G.A. (1960)Anal.Biochem. !,279 
85 Neher,R.(l964)in "Steroid Chromatography",2nd edn,pp.96-97, 
Elsevier Publishing Co,Amsterdam 
86 Lowry,O.H., Rosebrough,N.J., Farr,A.L. and Randall,R.J. (1951} 
J.Biol.Chem. !21,265-275 
87 Hall,P.F. (1965)Endocrinology 76,396 
88 Levier,R. and Spaziani,£. (1969)J.Exp.Zool. ~,113 
89 Brownie,A.C., van der Molen,H.J., Nishizawa,E.E. and Eik-Nes, 
K.B. (1964)J.Clin.Endocrinol.Metab . .£i,109l-1102 
90 de Jong,F.H. and van der Molen,H.J. (1970)Ann.Clinical Research 
2· 381-392 
91 Nayfeh,S.N. and Bagett,B. (1966)Endocrinology ~.460-470 
84 
92 Shikita,M., Ogiso,T. and Tarnaoki,B. {1969)Endocrinol.Japon. 
l:..§_,ll-16 
93 Bardin 1 W.C. and Lipsett,M.B. (1967)Steroids !,71-84 
94 Christensen,A.K. and Mason,N.R. (1965)Endocrinology .2.§.~646-656 
95 Ronmerts,F.F.G., van Doorn,L.G. 1 Galjaard 1 H. 1 Cooke,B.A. and 
van der Molen,H.J. (1973)J.Histochem.Cytochem. (accepted for 
publication) 
96 Tamaoki,B. and Shikita,M. (1966)in ''Steroid Dynamics'' 
(Pincus,G., Nakao 1 T. and Tait,J.F.,eds) ,pp.493-528,Academic 
Press,New York 
97 Dixon,M. {1953)Biochern.J. ~,170-171 
98 Eik-Nes,K.B. (1970)in ''The Androgens of the Testis'' 
(Eik-Nes,K.B. ,ed) ,pp.14-23,Marcel Dekker,New York 
99 Hall,P.F. {1970)in ''The Testis''(Johnson,A.D., Gomes,W.R. and 
VanDernark 1 N.L. ,eds) ,Vol.2, pp.18-31,Academic Press,New York 
100 Inano,H. and Tamaoki,B. (1966)Endocrinology ~,579-590 
101 Nayfeh,S.N. and Baggett,B. {1966)Endocrinology ~,460-470 
102 Gower,D.B. (1966)Steroids ~,511-526 
103 Ficher,M. and Steinberger,£. (1971)Acta Endocrinol. ~,285-292 
104 Steinberger,£. and Ficher,M. (1971)Endocrinology §..2_,679-684 
1()5 Folman,Y., Sowell,J.G. and Eik-Nes,K.B. (1972)Endocrinology .2..!.• 
702-710 
106 Coffey,J.C., French,F.S. and Nayfeh,S.N. (1971)Endocrinology 
§2_, 865-872 
107 Rivarola,M.A., Podest.3.,E.J. and Chemes,H.E. (1972) 
Endocrinology ~,537-542 
108 Rivarola,M.A.,and Podesta,E.J. (1972)Endocrinology 1Q,618-624 
109 Payne,A.H. and Jaffe,R.B. (1970)Endocrinology .§.2_,316-322 
110 Strickland,A.L., Nayfeh,S.N. and French,F.S. (1970)Steroids 
~.373-387 
111 Shikita,M., Ogiso,T. and Tamaoki,B. (1969)Endocrinol.Japon . 
..!....§_, 11-16 
112 Inano,H., Tsuno,K. and Tamaoki,B. (1970)Biochemistry !• 
2253-2259 
113 Sandberg,A.A., Rosenthal,H., Schneider,S.L. and Slaunwhite, 
W.R. (1966)in "Steroid Dynamics" (Pincus,G., Nakao,T. and 
Tait,J.F. ,eds) ,p.49,Academic Press,New York 
85 
114 Billiar,R.B. and Little,B. (1971)Endocrinology ~,263-266 
115 Billiar,R.B., Tanaka,Y., Knappenberger,M., Hernandez,R. and 
Little, B. { 1969) Endocrinology ~· 1152-1160 
116 Hamilton,M.A., McCune,R.W. and Roberts,S. (1972)J.Endocrinol . 
..2.,i. 297-315 
117 Gurpide,E. and Welch,M. {1969)J.Biol.Chem. ~,5159-5169 
118 Menini,E. and Norymberski,J. {1965)Biochem.J. ~,1-16 
119 Inano,H. and Tamaoki,B. (1966)Endocrinology 21,579-590 
120 van der Molen,H.J. {1968)in "Gas Phase Chromatography in 
Steroids"{Eik-Nes,K.B. ,ed) ,p.218,Springer Verlag,Berlin 
121 Fevold,H.R. and Eik-Nes,K.B. {1962)Gen.Comp.Endocrinol. l, 
506-515 
122 Schoen,E.J. (1964)Endocrinology ..z2,56-65 
123 Inano,I. and Tamaoki,B. {1968)Endocrinology .§1_,1074-1082 
124 Bedrak,E., samoiloff,v., Sod-Moria,u.A. and Goldberg,S. 
(1971) .J.Endocrinol. ~,489-498 
125 Bedrak,E. (1972)Gen.Comp.Endocrinol . .!...§._,525-533 
126 Schoen,E.J. and Samuels,L.T. (1965)Acta Endocrinol. ~,365-
127 Shikita,M. and Hall,P.F. (1967)Biochim.Biophys.Acta 136,484-497 
128 Baillie,A.H., Ferguson,M.M. and Hart,D.McK. (1966)in 
''Development in Steroid Histochemistry", p. 55 ,Academic Press, 
London 
129 Christensen,A.K. and Mason,N.R. (1965)Endocrinology 2£,646-656 
130 Hall,P.F., Irby,o.c. and de Kretser,D.M. (1969)Endocrinology 
~. 488-496 
131 Lacy,o. and Pettitt,A.J. (1970)Brit.Med.Bull. ~,87-91 
132 Bell,J.B.G., Vinson,G.P. and Lacy,O. (197l)Proc.Roy.Soc. 
Lond.B ll£,433-443 
133 Tamaoki,B. (1973)J.Steroid Biochem. ±,89-118 
134 Matsumoto,K. and samuels,L.T. (1969)Endocrinology 85,402-409 
135 Matsumoto,K., Monden,Y. and Samuels,L.T. (1972)in Abstract 22, 
Fourth Int. Congress of Endocrinology,Washington,Int. Congress 
Series ~,p.9,Excerpta Medica Foundation,Amsterdam 
136 van der Molen,H.J. and de Bruijn,H.W.A. (1971)in "Gonadal 
Steroid Secretion"(Baird,E. ,ed) ,pp.96-123,Edinburgh University 
Press,Edinburgh 
86 
137 Burstein,S. and Gut,M. (1971)Rec.Progr.Hormone Res. 21,324-326 
138 Galjaard,H., van Gaasbeek,J.H., de Bruijn,H.W.A. and 
van der Molen,H.J. (1970)J.Endocrinol. ~,li-lii 
139 Parvinen,M., Hurme,P. and Niemi,M. (1970)Endocrinology 87, 
1082-1084 
140 Parvinen,M. and Niemi,M. (1971)Steroidologica ~,129-137 
141 van Doorn,L.G., de Bruijn,H.W.A. 1 Galjaard,H. and 
van der Molen,H.J. (1973)Biol. of Reprod. (submitted for 
publication) 
142 van der Vusse,G.J., Kalkman,M.L. and van der Molen,H.J. (1973) 
Biochim.Biophys.Acta ~,179-185 
143 Oshima,H., Sarada,T., Ochiai,K. and Tamaoki,B. (1970) 
Endocrinology 86,1215-1224 
144 Cooke,B.A., de Jong,F.H., van der Molen,H.J. and Rommerts, 
F.F.G. (1972)Nature New Biology ~,255-256 
145 Strauss,J.F., Foley,B. and Stambaugh,R. (1972)Biol. of Reprod. 
~,78-86 
146 Kuhn,N.J. and Briley,M.S. (1970)Biochem.J. 117,193-201 
147 Bast,J.D. and Melampy,R.M. (l972)Endocrinology ~,1499-1505 
87 

Part 2 The role of K,3p-hydroxysteroids 
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2.1 Introduction 
2.1.1 Alternative pathways for steroid biosynthesis 
Steroid hormones can be formed along the 
steroid and the ~ 4 ,3-oxosteroid pathways (see 
5 t. ,3s-hydroxy-
GENERAL INTRO-
DUCTION, fig. 1). Possibilities for the existence of other 
pathways are, however, still being investigated. 
L'. 
4
,3-oxosteroid pathway 
Recently two reports were published concerning possible 
alternative routes in the ~ 4 ,3-oxosteroid pathway. Nakano 
1 
et al. described that the micro-organism Cladosporicum 
resinae can transform progesterone directly to testosterone 
acetate, by-passing 17 0 -hydroxyprogesterone and androstene-
dione. The testosterone acetate is subsequently hydrolized 
by an esterase to testosterone. However, testosterone ace-
tate could not be detected in rat testis and addition of an 
esterase inhibitor did not affect the rate of testosterone 
formation in vitro2 . Several other potential possible path-
ways from progesterone to c 17-steroids have been explored 
but the possibility of a route by-passing 17a-hydroxypro-
gesterone could not be established3 ' 4 . Therefore, it is 
generally accepted that the route along 17a-hydroxyproges-
terone and androstenedione is the predominant pathway from 
progesterone to testosterone in mammalian testis. 
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c.5,3~-hydroxysteroid pathway 
Recent investigations on alternative pathways have 
been concerned with the formation of 6 5 ,38-hydroxysteroids 
and the role of steroid sulfates in hormone production. 
Theoretically, biosynthesis of c19-steroids could occur 
through cl7,20-cleavage of cholesterol to dehydroepiandros-
terone, excluding pregnenolone and 17a-hydroxypregnenolone 
as intermediates. Burstein and Dorfman 5 and Gual et a1. 6 
indicated this possibility in the discussion of their 
results of an investigation in an 
claimed the existence of this new 
adrenal adenoma. 
7 8 pathway ' , when 
Jungmann 
he be-
lieved to have isolated radioactivity in an eightcarbon 
fragment, the 6-rnethylheptan-2-one, after incubation of 
26- 14c-cholesterol with homogenates of rat ovaries, testes 
and adrenal glands 7 and with acetone-dried powders of calf 
testes 8 . In a thorough reinvestigation of this problem 
Burstein et a1. 9 and Hochberg et a1. 10 could not obtain 
evidence for the formation of the c 8-fragment and it was 
concluded that Jungmann must have isolated an artefact. 
Shimuzu11 reported the conversion of 17a,20a-dihydroxy-
cholesterol to dehydroepiandrosterone by slices of normal 
human adrenal tissue, but again Burstein et a1. 12 found no 
evidence for the formation of dehydroepiandrosterone from 
either cholesterol or its l7a,20a-dihydroxyderivates by 
acetone-dried powders of guinea pig adrenals. In a review 
on the biosynthesis of pregnenolone, Burstein and Gut13 
reiterated these conflicting observations and they presented 
additional evidence for the obligatory role of c 20 , 22-
cleavage of cholesterol for steroid biosynthesis. 
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steroid sulfates 
Cholesterol sulfate occurs in a variety of mammalian 
tissues and has been shown to be converted to several ste-
roid sulfates in man in vivo 14 . Whether cholesterol sulfate 
only serves as a precursor of steroid sulfates 1 or whether 
it also participates in the biosynthetic pathways which 
lead to biologically active, unconjugated steroids is not 
entirely clear at present13 ' 14 . Moreover, a variety of tis-
sues is capable of sulfa-conjugation of steroids in vitro 15 
The complexity of the role of steroid sulfates can be demon-
strated by the findings of Telegdy et a1. 16 on steroid bio-
synthesis in the foetus at rnidgestation. They investigated 
the incorporation of 3H-cholesterol and 14c-acetate into 
steroids and found that pregnenolone and dehydroepiandros-
terone (free and conjugated) accounted for 95% of the ste-
roid products. The 14c; 3H ratio in these steroids, isolated 
from the conjugated fraction of the perfusates was much 
higher than that of the unconjugated compounds. They sug-
gested therefore that in the foetus acetate is utilized pre-
dominantly via the conjugated pathway, whereas circulating 
cholesterol is mainly converted via the unconjugated path-
way. 
A number of sulfate conjugated steroids are present in 
high concentrations in human testis 17 . The normal human 
testis secretes the {mono)-sulfates of testosterone, preg-
nenolone and possibly androstenediol 18 . After administration 
of HCG a considerable increase in the secretion of the 
mono-sulfates of dehydroepiandrosterone, androstenediol and 
pregnenolone was observed but no increase in the secretion 
of testosterone sulfate was found 19 . In vitro incubation 
studies with human 20 • 21 and rat 22 - 26 testes preparations 
demonstrated that steroid sulfates can be hydrolyzed to 
precursors of testosterone. In human testis this sulfatase 
activity correlates with serum testosterone levels and the 
"Leydig cell activity index" 21 . Although it has been shown 
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that steroid sulfatase activity is present in rat 
h . 27 the latter is not controlled by gonadotrop lns 
testis, 
The pre-
sence of steroid sulfates in rat testis has not been demon-
strated. 
Apart from being synthesized in testis tissue, steroid 
sulfates may also be supplied by the arterial blood. In per-
fusion experiments with dog testis it was demonstrated that 
after infusion of radioactive dehydroepiandrosterone sulfate 
a small conversion to testosterone occurred28 . In similar 
experiments with human testis hardly any labelled testoste-
rone could be detected29 , 30 , but this may be explained by 
the relatively short perfusion period (several minutes) , 
and dilution of the radioactive substrate with dehydroepian-
drosterone sulfate in human plasma. 
It is apparent that the relative importance of indivi-
dual intermediates or biosynthetic pathways may be different 
in the various species and in different endocrine glands. 
Furthermore the type of tissue preparation and the technique 
used to study the pathways will be of importance in this 
respect. 
2.1.2 Scope of this study 
Vander Molen and Eik-Nes 31 , who perfused dog testes 
. h bl d . . 3 14 b Wlt oo contalnlng H or C labelled pregnenolone o -
served that the specific radioactivity of the dehydroepian-
drosterone was much lower than that of l7a-hydroxypregneno-
lone, particularly during administration of HCG or 3' ,5'-
cAMP. This suggests that only a small fraction (5-10%) of 
the dehydroepiandrosterone originated from 17a-hydroxypreg-
nenolone and that precursors, other than pregnenolone, 
might be involved. Alternatively, incomplete mixing of the 
various labelled steroids with the tissue steroid pools 
might also explain their results. 
These results raise the question whether or not the 
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synthesis via ~ 5 ,36-hydroxysteroid sulfates contributes to 
the dehydroepiandrosterone formation or whether c 17 , 20 -
side-chain cleavage of cholesterol is possible under these 
conditions. In this respect it is noteworthy that the work 
of Burstein et al. 9 ' 12 , 13 on the side-chain cleavage of 
cholesterol was almost solely carried out with acetone-dried 
mitochondrial preparations. 
In the present study the role of b 5 ,3s-hydroxysteroids 
in testosterone production was investigated in detail. Tes-
tes from rabbits were used for this study because incuba-
tion experirnents 32 and preliminary perfusion experiments 
suggested that the b 5 ,3S-hydroxysteroid pathway is involved 
in testosterone biosynthesis in this species, like in the 
human testis 33 , 34 . The following aspects were investigated: 
1. The relative importance of the ~ 4 ,3-oxosteroid pathway 
and the ~ 5 ,3S-hydroxysteroid pathway for testosterone 
production. Special attention was given to the role of 
androstenediol as an intermediate. 
2. The existence of precursors of dehydroepiandrosterone 
and androstenediol other than pregnenolone and 17a-
hydroxypregnenolone. For this purpose rabbit testes were 
3 perfused in vitro with H-pregnenolone and the relation-
ship between the specific radioactivities of the secreted 
steroids was determined. During these perfusion experi-
ments the presence of steady-state conditions were main-
tained. A specific and sensitive technique was applied 
for the determination of ~ 5 ,3s-hydroxyste~oids, which 
had previously been developed for the determination of 
d d . d 35 ehy roeplan rosterone 
3. The presence of steroid sulfates and sulfatase activity 
in rabbit testis, because specific radioactivities of 
the steroid intermediates only give an indirect estimate 
of alternative biosynthetic pathways. 
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2.2 Materials and methods 
2.2.1 Methods for investigating pathways in steroid biosynthesis 
Many different techniques have been used to study the 
relative importance of pathways for steroid hormone biosyn-
thesis. Recent methods generally involve incubation or per-
fusion of endocrine tissue with two labelled precursors, 
with subsequent analysis of the labelled products. Occasio-
nally the production of steroids from endogenous sources is 
measured in addition to the conversion of labelled precur-
sor and this technique has been used in this study. Some of 
these methods are discussed below. 
Experiments with two labelled precursors 
Much information has been obtained 
incubation experiments, with separately 
from double 
labelled 3H 
label 
and 14c 
substrates. For example, when using 3H-pregnenolone and 
14 C-progesterone with steroid-forming tissues, the finding 
of a high 3H; 14c ratio in androstenedione may indicate the 
dominance of the ~ 5 ,38-hydroxysteroid pathway. This has 
36 37 been observed for the normal human ovary ' and a granu-
losa cell tumor 38 . The same principle was applied in incu-
b t . . . h . 39 ub . . th 3 a lOTI experlments Wlt horse testls . Inc atlon Wl H-
dehydroepiandrosterone and 14c-17a-hydroxyprogesterone was 
carried out for determining the importance of androstene-
diol as intermediate in testosterone biosynthesis in human 
testis 33 , 40 and rabbit testis. 
In order to obtain correct quantitative information on 
the relative importance of the various pathways, many ana-
lyses at various time intervals must be carried out and the 
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preferred pathway can then be derived from the sequential 
maxima in isotope incorporation of the different 
ducts 41 , 42 . From the results of incubations with 
pro-
3 H-pregne-
nolone and 14c-progesterone as substrates it was concluded 
that only the b 4 ,3-oxosteroid pathway is of importance for 
the rat testis interstitial tissue 43 and that in human tes-
tis the 6 5 ,3s-hydroxysteroid pathway dominates 33 . In the 
same way it was demonstrated that transformation through 
17a-hydroxypregnenolone was the major pathway for cortico-
steroid biosynthesis in an adrenal tumor 75 
Extrapolation of these results to the in vivo situa-
tion is difficult because the rate of penetration of added 
steroids into the tissue or differences in the binding of 
these substrates to the subcellular organella can influence 
the results 3 , 39 , 44 . The same disadvantages also hold for 
perfusion experiments which were performed with the human 
adrenal gland 45 and dog testis 46 with 3H-dehydroepiandroste-
14 
rone and C-17a-hydroxyprogesterone. 
A major disadvantage of nll these experiments is, how-
ever, that no direct information is obtained on the steroid 
production from endogenous sources and that alternative 
biosynthetic pathways from other precursors might be over-
looked. If tracer amounts of radioactive precursor are added 
to the incubation system, a homogeneous pool with the tissue 
endogenous precursors may not be formed 47- 49 . Addition of 
large amounts of precursor (either radioactive or non-radio-
active) decreases the relative contribution from endogenous 
sources and the biosynthetic pathway may then be biassed 
towards the contribution of the precursor; inhibition of 
the various steps of the pathway may also occur. 
Steroid production and conversion of labelled precursor 
One of the most important presumptions in the use of 
labelled compounds requires that the tissues endogenous 
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TISSUE 
production of A from 
endogenous sources 
100 pmoles/min 
350 pmoles 
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I 
0 
tD 
8 
tD 16000 dpm mon 
14000 dpm 
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BLOOD 
continuous infusion 
of radioactive A 
1600 dpm/pmin 
10 pmoles/min 
2000 dpm/min 
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1600 dpm/min 
40 pmoles/min 
S.A(B)=l60 ~ 
pmol 
S.A(C)=40 dpm 
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S.A(D)=40 ~ 
pmol 
Fig.15 Specific activities (S.A. dpm/pmol) of steroids A, B, C and D in a biosynthetic 
pathway when steady state conditions have been achieved during continuous 
infusion of radioactive steroid A. The open arrows represent the transfer rates or 
conversion rates of radioactive steroids (dpm/min), while the dark arrows represent these 
rates of the endogenous steroids (pmoles/min). The width of the arrows is proportional 
to the rate of transfer or of conversion. A second biosynthetic pathway to C, or a 
second, unlabelled tissue pool of C, causes a decreased specific activity of C, and 
subsequently of D. 
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precursors are metabolized along the same biosynthetic path-
ways as the added radioactive precursor. Zilversmit50 showed 
on theoretical grounds that under certain steady state con-
ditions the specific radioactivities of the products bore a 
definite relationship to one another. Assuming that steady 
state conditions are achieved through continuous perfusion 
with a trace amount of radioactive precursor A (fig. 15), 
it can be deduced that the specific radioactivity in the 
product B, c and D should be equal to each other and this 
is reflected by the specific activity in the fractions which 
are secreted. If, however, the specific activity in C is 
lower than that of B, another biosynthetic pathway or a 
second tissue pool contributes to unlabelled c 50 ' 51 . The 
ratio R of the specific activities gives the fraction of 
the product originating from the known precursor, 1-R re-
presents the fraction coming from unknown sources. 
R = specific radioactivity of product C 
specific radioactivity of precursor B 
Pulse labelling technique 
Steady state conditions are usually not achieved in 
normal incubation experiments or after a single injection 
of radioactive precursor in vivo. Nevertheless such experi-
ments can, if correct mathematical analysis is applied, lead 
to an understanding of the behaviour of steroids towards 
the individual tissue compartments and steroid pools in 
terms of transfer rates, conversion rates and tissue concen-
trations41,SO,S2. In the interpretation of these data it 
may appear that simplified models of metabolic processes 
often contain so many unknown parameters that agreement with 
experimental data looses its significance. It is ever. possi-
ble to design different models which all equally satisfy 
the experimental results 53 . 
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Constant infusion of radioactivity and the presence of a 
steady condition simplify the interpretation of the results 
and the estimation of unknown parameters, like transfer rates 
and conversion rates,becomes unnecessary. 
Steady state conditions can also be achieved by incu-
bation of tissue slices with frequent withdrawal of samples 
from the medium and addition of radioactive substrate or by 
applying the superfusion technique to tissue slices 42 ' 54 . 
2.2.2 Materials 
Some of the materials and basic techniques have alrea-
dy been described in paragraph 1.2. 
3 16- H-Pregnenolone (S.A. 21 Ci/mM) was purchased from 
C.E.N., Mol (Belgium). The manufacturer specified that more 
than 98% of the tritium was attached to carbon 16, although 
its steric location was not known. 4- 14c-Pregnenolone 
(S.A. 55.7 mCi/mM) was obtained from Radiochemical Centre, 
Amersham and the ammonium salt of 4- 14c-dehydroepiandroste-
rone sulfate (58.8 mCi/mM) from New England Nuclear Corpora-
tion (Boston). 
Androstenetrione was prepared as described by De Jong 
and Van der Molen 35 and was recrystallized successively 
from 1. methanol-water, 2. acetone-water and 3. cyclohexane-
ethylacetate. Yellow crystals were obtained (m.p. 214-217°C). 
This steroid is now commercially available (Steraloids Inc.). 
Pregnenetrione was obtained from Steraloids Inc .. HCG 
(Pregnyl, 3500 I.U./mg) and heparin were obtained from 
Organon (Oss). 
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2.2.3 Perfusion of rabbit testis in vitro 
Rabbits of the New Zealand White strain, weighing 
2.5-3.5 kg were used. The mean weight of a testis was 
3.5 ~ 0.6 g (S.D., n=l2). The perfusion medium was obtained 
as follows: A rabbit was killed by an intravenous injection 
of pentobarbital (200 mg), the chest cavity was opened, 
heart and lungs were removed and approximately 100 ml of 
blood was collected and heparinized (1500 I.U. per 100 rnl). 
The blood was diluted with an equal volume of Krebs-Ringer 
bicarbonate buffer (pH 7.4), containing bovine serum albumin 
(4 mg per 100 ml) and glucose (5 mM). 
For perfusion of the testis a rabbit was heparinized 
and anaesthetized with Hypnorm (Philips Dupha.r, S-10 rng 
Fluanison/kg bodyweight) . One testis was removed and freed 
from the caput ~pididymis and surrounding fat tissue. An 
incision of approximately 5 mm was made into the testis 
capsule, parallel with the main artery. This artery was 
dissected free from the tissue and was cannulated with a 
nr. 27 needle (Becton-Dickinson) with the aid of a binocu-
lar dissecting microscope. The testis was perfused for one 
minute with Krebs-Ringer bicarbonate buffer (pH 7.4). Sub-
sequently the cauda epididymis was tied to the needle in 
such a way that the testis could hang unsupported on the 
needle. The testis was brought into the perfusion chamber 
and the perfusion was started (within 8-10 minutes after 
removal from the rabbit). 
The perfusion apparatus was essentially the same as 
described by Ewing and Eik-Nes 55 and a modification from 
that of VanDemark and Ewing56 (fig. 16). The temperature 
of the perfusion chamber and oxygenator was maintained at 
37°c 57 by means of water circulating through the surroun-
ding jacket. The blood was oxygenated with humidified oxy-
gen (5% carbon dioxide) and was filtered through nylon 
gauze and circulated by a peristaltic pump (Buchler Instru-
ments). Before entering the perfusion chamber, the blood 
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2 oxygenator 
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7 organ chamber 
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Fig.16 Apparatus for perfusion of rabbit testis in vitro. 
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was filtered again and passed through a bubble trap. The 
temperature was measured by a NTC resistor probe placed near 
the testis. The pressure was regulated with a pressure valve 
in a by-pass tube. During the perfusion experiments it was 
necessary to increase the pressure gradually from 60 rnm to 
90 or 100 rnrn of mercury in order to obtain a constant flow 
rate. The testicular venous blood was collected for periods 
of 30 minutes in a calibrated cylinder placed in an ice-
bath. The range of blood flow;achieved in several experi-
ments was 15 to 30 ml per 30 minutes. A non-pulsative blood 
flow was maintained because this presumably is also found 
in vivo. Waites and Maule reported that in the ram a pulse-
pressure reduction occurs in the arterial coils in the 
spermatic cord so that the testis receives a relatively 
pulseless flow58 . The glucose level in the blood was main-
tained by addition of a glucose solution into the reservoir 
every hour at a rate of 1 ~mol per ml of blood per hour 56 . 
HCG, which was dissolved in 0.9% NaCl solution was added in 
amounts varying from 150 to SOD I.u. (0.63 ml) per 30 minu-
tes. Radioactive substrates, e.g. 16- 3H-pregnenolone 
(1.3x10 6 dpm per 0.63 ml per 30 minutes) were dissolved in 
0.9% NaCl solution, containing 4% bovine serum albumin in 
order to decrease absorption to the polyethylene tubing59 
These substances were introduced into the circulation with 
an infusion pump. At the end of the experiment the testis 
was immediately frozen in liquid nitrogen. 
The following radioactive substrates have been used. 
3 14 1. A mixture of 16- H- and 4- c-pregnenolone in order to 
2. 
check the stability of the 16- 3H-label in the steroid 
molecule. 
3 7a- H-17a-Hydroxyprogesterone with and without addition 
of HCG in order to establish the significance of the 
65 ,3S-hydroxysteroid pathway. 
3. 16- 3H-Pregnenolone, and addition of HCG was started 
after two hours of perfusion. 
4. 3 16- H-Pregnenolone, with continuous addition of HCG. 
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2.2.41solation and estimation of steroids 
Specific radioactivities of the steroids in plasma and 
tissue samples were measured after isolation and purifica-
tion. For estimation of the amount of steroid, the purified 
compounds were converted to derivatives with a high electron 
capturing ability,which permitted sensitive estimation after 
gas-liquid chromatography. Quantitative estimations of tes-
tosterone and dehydroepiandrosterone were performed in the 
same samples after the addition of tracer amounts of 14c-
labelled steroids for recovery determinations. 
The testicular venous blood samples were separated into 
plasma and erythrocytes by centrifugation. The erythrocytes 
were washed twice with 10 ml of a 0.9% NaCl solution con-
taining 0.5% bovine serum albumin and were centrifuged. 
Plasma and the wash fractions were combined and 4- 14c-
testosterone (20,000 dpm) and 4- 14c-dehydroepiandrosterone 
(10,000 dpm) were added. Extraction was carried out with 
ethyl acetate (4x20 ml). Alkaline-ether extraction was not 
applied because of the possible 3H-elimination from 17-oxo-
steroids (see paragraph 2.3.1). The combined extracts were 
washed twice with 5 ml of water and evaporated to dryness 
under reduced pressure. 
Frozen testis tissue was homogenized, extracted and 
defatted as described in paragraph 1.2.8, after addition of 
14
c-steroids (see above). 
Fig. 17 gives an outline of the isolation and purification 
procedure. Details of the methods for acetylation, enzymic 
reduction of androstenedione and chloroacetylation of tes-
tosterone are given in paragraphs 1.2.4 and 1.2.5. Hydro-
lysis of steroid acetates was performed in 1.0 ml of metha-
nol containing 0.2 ml of a O.SM NaOH-solution, for 45 minu-
tes at 50°C. The solution was then concentrated by evapora-
tion to a volume of approximately 0.3 ml and extracted with 
ethyl acetate (3x2 ml). The ethyl acetate fraction was 
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washed with water and evaporated to dryness. The 17a-
hydroxypregnenolone fraction was reduced for 90 minutes by 
5 mg of sodium borohydride dissolved in 0.5 ml of metha-
nol31. The reaction was stopped with the addition of a drop 
of acetic acid and 2 ml of water. This mixture was extracted 
by 4x2 ml of ethyl acetate. Oxidation of steroids to andros-
tenetrione was carried out for 10 minutes with 0.5 mg of 
chromiumtrioxide, dissolved in 0.1 ml of 90% acetic acid35 . 
Estimation of known amounts of 17a-hydroxypregnenolone 
showed that the recovery of steroid with this procedure was 
in the range of 10 to 15%. With this procedure in the order 
of 10 to 30 pmoles of 17a-hydroxypregnenolone could still 
be detected in spermatic venous blood samples (fig. 18). The 
recovery of the androstenediol through the purification 
steps was in the order of 20%. 
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Fig.18 Tracings obtained after gas liquid chromatography of androstenetrione (A), 
obtained from 170::-hydroxypregnenolone, which was isolated from a 30 minutes 
sample of testicular venous blood of HCG stimulated rabbit testis. Pregnenetrione 
(P, 33 pmoles) was added as internal standard and two-thirds of the sample was 
analysed, 
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Specific activities of the purified steroids were measured 
as follows. After addition of an appropriate amount of in-
ternal standard (20a-dihydroprogesterone chloroacetate or 
pregnenetrione35 ), a sample of the mixture was taken for 
measurement of 3n- and 14c-radioactivity and the mass of 
steroid was estimated in a second sample by gas chromato-
graphy with electron capture detection (paragraph 1.2.2 and 
reference 35). The specific activity was calculated as the 
ratio of the radioactivity ( 3H dpm) and the mass of the 
steroid (pmoles). The amounts of testosterone and dehydro-
epiandrosterone in testicular venous blood and in testis 
tissue were calculated from the mass, estimated by gas 
14 
chromatography, and the recovery of the added C-labelled 
internal standard. The radiochemical purity of the dehydro-
epiandrosterone and 17a-hydroxypregnenolone fraction was 
checked by taking a sample of the corresponding androstene-
trione fractions after gas chromatography. 
Such dehydroepiandrosterone-androstenetrione fractions were 
then purified by chromatography in a Bush AII system toge-
ther with 50 ~g of carrier androstenetrione. Androstene-
trione has a remarkable low Rf-value in this system when 
compared to steroids with approximately the same polarity, 
possibly due to enolisation of the ~ 4 ,3,6-di-oxogroup in 
the stationary methanol-water phase. This property facili-
tated the purification procedure. After elution from the 
3 paper,a sample of the androstenetrione was counted for H-
and 14c-radioactivity. Specific activities were corrected 
with a factor calculated either from the shift in 3n; 14c 
ratios or from the absolute 3n-radioactivity, corrected for 
losses after estimation of the recovery of the carrier 
androstenetrione by gas chromatography. The mean drop in 
specific activity of androstenetrione after purification 
was 12% (25 samples). 
The radiochemical purity of the 17o:-hydroxypregneno!one 
3 fraction was evaluated by recrystallization of pooled H-
androstenetrione samples with carrier steroid (see paragraph 
2.3.4). When the androstenediol fraction was purified in the 
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same way as described for the dehydroepiandrosterone, no 
decrease in specific activity was observed and therefore 
this fraction was regarded as radiochemically pure. The 
testosterone fractions were known to be pure from prelimi-
nary experiments in which an extra purification step via 
testosterone acetate was employed (as in paragraphs 1.2.4 
and 1.2.6). The 3H; 14c ratio of the testosterone acetate 
and of the final product testosterone chloroacetate did not 
significantly differ from each other: 
3H; 14c in testosterone chloroacetate 
H/ C in testosterone acetate 
0.96 + 0.04 (S.D., 
13 samples) 
An assessment of reproducibility of the method for 
estimation of specific activities was made by dividing a 
purified androstenetrione sample (obtained from plasma 
dehydroepiandrosterone) into ten fractions, each containing 
approximately 60 pmoles of the steroid. The mean specific 
activity was found to be 98.4 + 2.1 dpm 3H per pmol (S.D., 
10 estimations). 
The accuracy and precision of the steroid estimations 
were evaluated by determination of known amount of steroids 
simultaneously with biological samples (table 15). 
Table 15 ESTIMATION OF KNOWN AMOUNTS OF STEROIDS 
Steroid added found number of 
{ng) (ng + S.D.) estimations 
testosterone 1000 ng {3.4 nmoles) 1050 + 80 ng 6 
100 ng 107 ~ 14 ng 18 
dehydroepian- 100 ng {0.34 nmo1es) 103 + 13 ng 24 
drosterone 
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2.2.5 Estimation of steroid sulfatase activity and steroid sulfates 
Rat testes (2.5 g) and rabbit testis (2.9 g) were 
homogenized in 15 rnl of O.OSM TRIS buffer (pH 7.4) using a 
Potter Elvejhern homogenizer. The microsomal fraction was 
isolated by differential centrifugation {lO,OOO-lOS,OOOxg). 
Steroid sulfatase activity was determined according to 
Payne 20 using dehydroepiandrosterone sulfate as a substrate. 
Time-product relationships are given in fig. 19. Enzyme 
activity in rabbit testis was calculated on the basis of 
the conversion during 15 minutes of incubation. 
Testes of rats and rabbits were washed with 0.9% NaCl 
solution via injection into the spermatic artery in order 
to remove plasma steroid sulfates (if present) from the 
tissue. Steroid sulfates were isolated from testis tissue 
17 . 14 
and plasma by the method of Ruokonen , us1ng 4- c-
dehydroepiandrosterone sulfate (6,000 dprn) as internal 
standard. Steroid sulfates were separated from free steroids 
nmoles 
0.5 
0 
0 
RAT SULFATASE 
15 
time 
S ( ~M) 
35 
12 
3.5 
1.2 
30 
(min) 
RABBIT SULFATASE 
nmoles 
S ( I'M) 
0.2 
0.1 
0 
0 15 30 
time (min) 
Fig. 19 Relationship between amount of product (pmoles) and incubation time (min} for 
the hydrolysis of 14C-dehydroepiondrosterone sulfate during incubation with the 
10,00'0 - 105,000 x g fraction of rat and rabbit testes (0.49 and 0.55 mg of protein 
respectively per incubation). The substrate concentrations ($) are given in the figures. 
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on Sephadex LH-20 columns 17 Solvolysis was performed accor-
ding to Burstein and Lieberman60 . The free dehydroepian-
drosterone and androstenediol were separated by t.l.c., 
oxidized by chromiumtrioxide and estimated as androstene-
trione, according to the method of De Jong and Van der 
Molen 35 . The androstenediol concentrations in the original 
samples were calculated with aid of the mean recovery for 
14
c-dehydroepiandrosterone sulfate. The sensitivity of the 
method was in the order of 20 pmoles of dehydroepiandroste-
rone sulfate. After analysis of 230 pmoles of dehydroepian-
drosterone sulfate, simultaneously with the biological 
samples, 182 and 185 pmoles were found. After estimation of 
the sulfates of dehydroepiandrosterone and androstenediol 
in peripheral male plasma, the concentrations found were in 
the same order as reported previously35 , 61 
The statistical significance of apparent differences 
between results were calculated using student t-test. 
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2.3 Results 
2.3.1 Elimination of tritium from metabolites of 16-3 H-pregnenolone• 
Radioactive substrates with high specific activities 
were required for the perfusion experiments since these 
cause minimal disturbance of the endogenous steroid pools. 
Pregnenolone, labelled with tritium in the ?a-position could 
not be used, because the 7a- 3H-label is lost when ~ 5 ,36-
hydroxysteroids are oxidized to the corresponding ~ 4 ,3,6-
dioxosteroids before g.l.c. estimation35 , 62 . l6- 3H-Pregne-
nolone had the required high specific activity, but during 
the first series of experiments it appeared that the tritium 
label was eliminated from some of the steroid products. This 
loss of 3H-label must have occurred either during metabolism 
or during the isolation procedures. Because it was important 
to know whether the loss of 16- 3H occurred during a metabo-
lic conversion or was due to an artefact during the isola-
tion, a mixture of 16- 3H- and 4- 14c-pregnenolone was infused 
into the testicular arterial blood. Elimination of tritium 
would then result in a decrease of the 3H; 14c ratio in the 
secreted steroids, as compared to the 3H; 14c ratio in the 
original pregnenolone. 
The 3H; 14c ratios of the isolated steroids, as given 
in table 16, are similar in the precursor pregnenolone and 
its metabolites. This proves that tritium was not elimina-
ted during the metabolism of pregnenolone and that 16- 3H-
l4 
and 4- C-pregnenolone were metabolized in the same way. 
*de Bruijn, H.W.A. and van der Molen, H.J. (1973} 
J.Steroid Biochem. i,BS-87 
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Table 16 3H; 14c RATIOS IN STEROIDS isolated from the testicular 
venous blood after simultaneous infusion of 16- 3H- and 
14 6 3 6 14 4- C-pregnenolone (21.Sxl0 dpm Hand 0.67x10 dpm C, corres-
ponding with 5.6 nmoles of pregnenolone per 30 minutes). Mean 
values and S.D. of six estimations are given. 
Steroid isolated estimated as 3H/14c 
pregnenolone pregnenolone acetate 31.9 + 
testosterone testosterone chloro- 31.7 + 
acetate 
androstenedione testosterone chloro- 30.4 + 
acetate 
Sa-androstane-36, Sa-androstane-36,176- 33.9 + 
176-diol diol di-chloroacetate 
androstenediol 4-androstene-3,6,17- 33.9 :'c 
trione 
17a-hydroxypregnenolone 4-androstene-3,6,17- 34.5 :'c 
trione 
However, after alkaline hydrolysis of isolated 
droepiandrosterone acetate the 3H; 14c ratio was 2.2 
thus 93% of the 16- 3H-label was eliminated. When in 
0. 9 
0. 1 
0. 6 
1.0 
2.9 
3. 3 
dehy-
+ 0.1, 
a sepa-
rate experiment dehydroepiandrosterone was isolated and 
purified without acetylation and alkaline hydrolysis, no 
elimination of tritium was found {3H; 14c in dehydroepian-
drosterone was 29.2 ~ 0.2, in pregnenolone 27.5 ~ 2.5, 4 
estimations) . When the androstenetrione obtained from an-
drostenediol was further purified by ether-alkali parti-
tion63, the ratio dropped from 33.9 to 3.3, indicating a 
90% loss of tritium. More than 80% of this tritium was pre-
sent in the acidified water phase. In a control experiment 
lll 
the isolated and purified androstenedione was exposed to 
the methanolic alkali solution as used for hydrolysis. This 
resulted in a tritium loss of 90.4 ~ 4.1% (7 estimations). 
Acetates of 17S-hydroxysteroids could be subjected to alka-
line hydrolysis without loss of the 16- 3H-label. The acetic 
acid, used in the oxidations, did not promote the loss of 
the tritium at carbon atom 16. 
Base-catalysed enolisation of the 17-oxogroup offers 
a suitable explanation for these observations. These results 
are in agreement with those of Fishman64 , who demonstrated 
3 3 that both the 16a- H- and 166- H-label are removed from 
estrone benzoate by enolisation of the 17-oxogroup. 
From these results it can be concluded that 16- 3H-
pregnenolone can successfully be used in investigating 
steroid metabolism only if alkaline treatment of the meta-
bolites with a 17-oxogroup is avoided. 
2.3.2 Secretion of steroids by the perfused rabbit testis 
Besides testosterone, the following steroids have been 
detected in the testicular venous blood of the perfused 
rabbit testis: 17a-hydroxypregnenolone, dehydroepiandroste-
rone, androstenediol and androstenedione. The secretion of 
these steroids is the result of de novo synthesis and not 
of a passive leakage of stored steroid from the testis 
(table 17). Secretion of dehydroepiandrosterone, androstene-
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Table 17 LEVELS OF STEROIDS IN RABBIT TESTIS (nmoles/testis) AFTER CONTINUOUS PERFUSION 
WITH HCG {150-500 I.U./min) FOR 2 HOURS AND RATES OF SECRETION (nmoles/30 min, 
ranges are given). 
testis 
Exp. weight testosterone dehydroepiandrosterone androstenediol * 
---
g level secretion level secretion level secretion 
1 3. 9 10.0 16 - 30 0.86 1.2- 2.5 0.30 0.49- 0.78 
2 3. 5 3. 8 6. 4 - 7. 9 0.38 l. 1 - 1.7 0.13 0.30 - 0.50 
3 3. 7 6. 1 12 - 16 l. 06 1.5- 2.3 0.19 0.41- 0.54 
4 3. 1 4. 9 8.4 - 16 0. 61 l.l- 1.8 0.05 0.05 - 0.12 
5 3. 5 7.9 9.8- 17 0. 42 0.6- 1.7 0.18 0.13 - 0.43 
• Androstenediol values were not corrected for losses, caused by the isolation procedure. 
The recovery of known amounts of androstenediol was in the order of 20%. 
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Fig.20 and 21 Time course relationship of testosterone (fig. 20) and 
dehydroepiandrosterone secretion rates (fig.21) by the perfused rabbit 
testis. Mean values and S.E.M. are given (6 to 8 observations). 
---------- continuous HCG infusion (150-500 IU/30 min) 
----- HCG infusion started after 2 h of perfusion 
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diol and other intermediates also occurs in the human tes-
tis19,65 and dog testis 66 , 31 in vivo and is therefore not 
regarded as an artefact of in vitro perfusion experiments. 
The steroid secretion rate and the ability of HCG to promote 
steroid secretion have been used as parameters for the 
functioning of testes during the experiments. The secretion 
of testosterone and dehydroepiandrosterone with and without 
addition of HCG are represented in fig. 20 and 21. If addi-
tion of HCG was omitted, the secretion of these steroids 
decreased during the experiment, as has been observed ear-
lier for rabbit67 and dog testis perfusion68 . The testoste-
rone secretion (without administration of HCG) by rabbit 
testis in vivo was estimated as 4.3 + 1.1 nmoles per 30 min 
(S.E.M., 4 estimations) and this is significantly lower 
(P < Q.01) than the secretion during the first 30 minutes 
of perfusion, but comparable to the secretion during the 
second hour. HCG infusion, starting after two hours of per-
fusion, increased the steroid secretion to the same values 
as obtained for continuously stimulated testes. Secretion 
of 17a-hydroxypregnenolone and androstenedione was also 
increased by HCG. The administered doses of HCG caused a 
maximally stimulated testis since increasing the infusion 
rate from 150 to 500 I.U. per 30 min did not result in 
higher testosterone secretion. In this series of experiments 
no correlation could be found between testis weight and 
steroid secretion. 
From the results in fig. 20 it can be seen that tes-
tosterone secretion was constant during continuous HCG in-
fusion and it can be expected that under these condtions a 
steady state incorporation of infused radioactive steroid 
precursor may be obtained. 
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2.3.3 The importance of the ll5,3{3-hydroxysteroid pathway 
It was tried to determine the relative importance of 
the 6 5 ,36-hydroxysteroid pathway in the intact perfused 
rabbit testis by infusion of tracer amounts of 7a- 3H-17a-
hydroxyprogesterone and subsequent estimation of the speci-
fic activities of the secreted androstenedione and testos-
terone (table 18). The specific activities of the secreted 
androstenedione and testosterone indicate that a steady state 
condition was only achieved in the first experiment. In the 
other experiments the ratio of specific activities continued 
to decrease with the duration of the experiment and it was 
concluded that only a fraction of the endogenously synthe-
sized testosterone originated from androstenedione. It was 
calculated that in experiment 1 about 70% and in experiment 
2 more than 90% of the testosterone was synthesized from 
androstenediol. During HCG stimulation more than 97% of the 
testosterone was derived from androstenediol. 
In later experiments 16- 3H-pregnenolone was infused, 
so that both 65 ,3s-hydroxysteroids and 6 4 ,3-oxosteroids 
were labelled. The ratio of specific activities of andros-
tenedione over testosterone was, as might be expected, not 
significantly different from unity, 0.89 + 0.12 (S.E.M., 
4 per fusions). 
5 Although the exact contribution of the 6 ,36-hydroxy-
steroid pathway could not be calculated, it is evident from 
these results that this route with androstenediol is the 
main pathway for testosterone production in rabbit testis. 
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Table 18 SPECIFIC ACTIVITIES (dpm/pmol) OF TESTOSTERONE AND ANDROSTENEDIONE secreted by rabbit 
testis during continuous infusion with 7a- 3H-17a-hydroxyprogesterone {1.3xl06 dpm and 
0.06 pmoles per 30 min). In experiments 3 and 4 HCG was infused (200 I.U. per 30 min). The ratios 
of the specific activities of testosterone to androstenedione have been calculated. 
testosterone specific activities 
Exp. period secretion ratio 
(min) {nmoles/30 min) testosterone androstenedione 
1 control 0 - 30 2. 4 46.5 61.5 0.76 
30 - 60 5.3 22. 1 56.9 0.39 
60 - 90 4. 8 22.4 54.9 0.41 
90 - 120 3. 5 26.1 101 0.26 
120 - 150 4. 4 27.7 79.2 0.35 
2 control 0 - 30 3. 8 28.3 63 0.45 
30 - 60 6. 1 20.1 143 0. 14 
60 - 90 3. 6 18.4 264 0.07 
3 HCG 0 - 30 12.4 8.9 262 0.03 
30 - 60 11.3 10.4 337 0.03 
60 - 90 6. 7 12. 4 753 0.02 
4 HCG 0 - 30 5. 5 11.5 523 0.02 
30 - 60 5. 4 22.3 2290 0. 01 
60 - 90 3.6 36.7 5870 0. 0 l 
2.3.4 The relationship between specific radioactivities in 
c.5,3/3-hydroxysteroids and testosterone 
Rabbit testes were continuously perfused with 16- 3H-
pregnenolone and HCG. The difference in specific activities 
of infused pregnenolone and secreted testosterone shows that 
more than 99% of the mass of testosterone was derived from 
endogenous sources (fig. 22). The constant secretion rate 
of dehydroepiandrosterone and testosterone in this series 
of experiments was already shown in fig. 20 and fig. 21. 
The specific activities of these steroids in the testicular 
venous blood also remained constant throughout the experi-
ments (fig. 22). Thus, a steady state situation with res-
pect to steroid secretion was obtained. The equilibrium be-
tween endogenous steroid production and conversion of 3H-
pregnenolone is also demonstrated by comparison of the spe-
cific activities of steroids in the last blood samples with 
those of the testis tissue (table 19). The ratios of these 
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Fig.22 Specific activities of testosterone and dehydroepiandrosterone secreted by 
rabbit testis in vitro, during continuous infusion of 16-3H-pregneno!one 
(specific activity 46xl03 dpm per pmol). Mean values and S.E.M. are given (5 or 6 
observations). Continuous administration of HCG (150-500 IU per 30 min) has been 
applied (same series of experiments as in fig.20 and 21 ). 
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Table 19 SPECIFIC ACTIVITIES OF STEROIDS IN SPERMATIC VEIN BLOOD 
AND IN TESTIS TISSUE. The mean ratios of the specific 
activity in the last blood sample over the specific activity in 
the testis tissue are given, together with S.E.M. and number of 
observations {n) . 
steroid ratio S.E.M. n 
testosterone 1.16 ~ o.os 6 
androstenedione 0.93 + 0.15 4 
androstenediol 1.54 + 0.41 6 
dehydroepiandrosterone 1.55 + 0.42 5 
specific activities did not significantly differ from unity. 
The achievement of a steady state situation in a relatively 
short time is apparently favoured by the short "turn-over 
time" (10-20 min) of steroids in the testis, as can be con-
cluded from the results in table 17. 
The ratio of specific activities in product and pre-
cursor was calculated. Specific activities of a particular 
steroid, isolated from different perfusions after the same 
time period, showed a relatively large variation and there-
fore this ratio was not calculated from the mean values of 
specific activities. Hence, the ratio was calculated from 
the specific activities in product and precursor in each 
sample. Mean ratios and their standard errors were plotted 
against the time (fig. 23). 
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Fig, 23 Time course relationship of ratios of specific activities of steroids in testicular 
venous blood (same series of experiments as in fig. 22). 
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Mean values and S.E.M. are given (4 to 6 observations, except at 3~ and 4 h.). 
3 During perfusion with H-pregnenolone both androstene-
diol and androstenedione were labelled. These two steroids 
are considered as the only direct precursors of testoste-
rone and since androstenediol is by far the most important 
precursor during HCG administration (see paragraph 2.3.3), 
the specific activities of this precursor and testosterone 
should equal each other. After 30 to 60 min of perfusion 
the ratio of these specific activities did not differ sig-
nificantly from unity (fig. 23), thus the techniques used 
appeared to be reliable and another proof for the presence 
of steady state conditions was obtained. 
Surprisingly after 30 minutes of perfusion the speci-
fic activity of androstenediol in the venous blood was sig-
nificantly lower (P < 0.025) than that of dehydroepiandros-
terone (fig. 24) .The ratio 6f specific activity of product 
over precursor was in the order of 0.6. Because the speci-
fic activities of steroids in spermatic venous blood were 
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Fig. 24 Time course relationship of ratios of specific activities of steroids in 
testicular venous blood (same series of experiments as in fig.22). 
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Mean values and S.E.M. are given (4 observations). 
not significantly different from the specific activities of 
the same steroids in testis tissue (table 19) these results 
indicate that approximately 40% of the androstenediol might 
have originated from other sources than dehydroepiandroste-
rone. Since the testosterone secretion rate exceeded 
10 nmoles/30 min (fig. 20), this unknown source of andros-
tenediol may account for approximately 4 nmoles/30 min. It 
is evident that the tissue pool of unlabelled androstene-
diol was too small to deliver this amount (table 17) and 
therefore this ratio cannot be explained by the absence of 
steady state conditions. These data can only suggest that a 
second, yet unknown pathway results in de novo synthesis 
of androstenediol. This pathway should also by-pass 17a-
hydroxypregnenolone, because the specific radioactivity of 
dehydroepiandrosterone nearly equals that of !?a-hydroxy-
pregnenolone {see below). 
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Table 20 RECRYSTALLIZATION OF THE 3H-ANDROSTENETRIONE, ORIGINATING FROM 3H-17a-HYDROXYPREGNENO-
LONE. Fractions, isolated from the testicular venous blood of one perfusion experiment 
were pooled. After addition of 30 mg of androstenetrione, recrystallization was performed from the 
following solvent mixtures: l. methanol-water. 2. acetone-water. 3. cyclohexane-ethyl acetate. The 
radioactivity in the samples was estimated with a counting error of 6% or less. The purity was 
calculated from the change in specific activities. 
Perfusion 
nr. 
2 
3 
4 
nr. 
crystallization 
0 
2 
3 
0 
2 
3 
0 
2 
3 
0 
2 
3 
specific activities (dpm 3H/mg) 
crystals 
519 
438 
375 
327 
432 
284 
245 
246 
281 
164 
119 
110 
199 
178 
168 
176 
mother liquor 
872 
574 
551 
245 
594 
259 
131 
375 
194 
mean radiochemical purity 
of androstenetrione 
c; 63% 
56% 
39% 
87% 
Table 21 RELATIONSHIP BETWEEN THE SPECIFIC ACTIVITIES OF 17a-
HYDROXYPREGNENOLONE AND DEHYDROEPIANDROSTERONE, 
secreted by the rabbit testis after infusion with 3H-pregneno-
lone. The values for 17a-hydroxypregnenolone are corrected for 
the radiochemical impurities, as shown by the recrystallizations 
of the pooled fractions (table 20). 
The ratios specific activity 
spec1 lC actlVlty o 
are given. 
Perfusion time specific activity (dprn/pmol) 
experiment period 17a-hydroxypreg- dehydroepian- ratio 
min 
nenolone (corrected) drosterone 
1 0 - 30 1042 928 0.89 
30 - 60 1044 819 0.78 
60 - 90 1238 779 0.63 
90 - 120 921 969 1. OS 
2 0 - 30 462 
30 - 60 1000 511 0.51 
60 - 90 592 355 0.59 
90 - 120 447 403 0.90 
3 0 - 30 628 513 0.82 
30 - 60 317 453 1. 42 
60 - 90 681 520 0.76 
4 0 - 30 982 954 0.97 
30 - 60 608 437 0.72 
60 - 90 779 610 0.78 
mean ratio 
0.84 :!: 0.07 
(S.E.M., 
4 perfusions) 
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A preliminary experiment showed that the specific acti-
vity of 17a-hydroxypregnenolone was higher than that of 
dehydroepiandrosterone, however, the 3H-androstenetrione, 
corning from 17a-hydroxypregnenolone, was radiochemically 
impure. Because of the small amount of radioactivity 
(1500 to 4000 dprn 3H) in these fractions it was not possible 
to perform repeated recrystallizations with added androste-
netrione. Therefore androstenetrione samples from one per-
fusion experiment were pooled after mass determination with 
g.l.c .. These combined samples were subsequently recrystal-
lized with authentic androstenetrione (table 20). The found 
mean radiochemical purity of the combined sample was used 
to correct the specific activities of 17a-hydroxypregneno-
lone and these values were compared with the specific acti-
vities of dehydroepiandrosterone (table 21). 
Although the mean value for the ratio of specific acti-
vities 0.84 + 0.07 (S.E.M.) differs from unity (0.025 < P < 
0.05), it is questionable if during HCG administration any 
dehydroepiandrosterone comes from other sources than 17a-
hydroxypregnenolone. This small difference in specific ac-
tivities may be caused by an error in estimating the average 
specific activity because complete radiochemical purity was 
probably not obtained in all the recrystallized fractions. 
2.3.5 Steroid sulfatase and steroid sulfates 
In order to explain a possible contribution to andros-
tenediol synthesis from a steroid sulfate source, the pre-
sence of steroid sulfatase and steroid sulfates in the rab-
bit testis was investigated. The rabbit testis was found to 
have steroid sulfatase activity (fig. 25) with an apparent 
Krn-value in the same range as had been measured for rat 
testis 25 , 26 . The maximal conversion rate, as measured for 
dehydroepiandrosterone sulfate, was 1 nmol per 30 minutes 
per mg of microsomal protein. 
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Fig.25 Steroid sulfatase activity in the 10,000-105,000 x g fraction of rat and rabbit 
testis, represented in a Lineweaver-Burk plot. Velocity is expressed as nmoles 
dehydroepiandrosterone sulfate hydrolysed during 30 minutes per mg of protein. 
The testes and peripheral plasma from rabbits were 
analysed for the sulfates of androstenediol and dehydro-
epiandrosterone. The sensitivity of the method used was 
20 pmoles. In the tissue both steroid sulfates were not 
detectable. In plasma the concentration of dehydroepiandros-
terone sulfate was too low to be estimated but the level of 
androstenediol monosulfate was found to be 1.7 + 0.8 nrnoles/ 
100 ml plasma (S.E.M., 4 estimations). 
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2.4 Discussion and conclusions 
The relafiVe importance of the ~:;.5 ,3~-hydroxystero.,d pathway and 
androstenediol for steroid biosynthesis when compared with the 
e:,.
4 
,3-oxosteroid pathway 
Rosner et a1. 32 have reported that androstenediol con-
tributes significantly to the testosterone production in 
rabbit testis. They carne to this conclusion after incubating 
rabbit testis hornogenates with 3H-dehydroepiandrosterone 
14 
and C-17a-hydroxyprogesterone. From their data it can be 
derived that about one third of the labelled testosterone 
was synthesized via androstenediol. The results of the pre-
sent perfusion experiments with tracer amounts of 3H-l7a-
hydroxyprogesterone indicated that 70% or more of the tes-
tosterone was derived from androstenediol. These latter 
results may well give a better quantitative impression of 
the role of androstenediol in vivo because the conditions 
used are more physiological. It is likely that the role of 
androstenediol in the human testis has also been underesti-
mated because the data were also obtained from in vitro 
incubation33 , 40 . 
Possible alternative pathways in the biosynthesis of 
t:.~3p-hydroxysteroids in rabbit testis 
In HCG stimulated rabbit testis dehydroepiandrosterone 
was almost exclusively derived from l7a-hydroxypregnenolone 
(see paragraph 2.3.4). This observation is consistent with 
the conclusion obtained by Burstein and Gut 13 for adrenal 
tissue. Extensive purification of the l7a-hydroxypregneno-
lone fraction appeared to be necessary before radiochemical 
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purity was obtained. The large difference in specific acti-
vities of 17a-hydroxypregnenolone and dehydroepiandrosterone 
found in perfusion experiments with dog testis 31 may thus be 
explained by impurities in the 17a-hydroxypregnenolone frac-
tions. 
The difference between the specific activities of de-
hydroepiandrosterone and androstenediol during HCG adminis-
tration may indicate the presence of a second, yet unknown 
biosynthetic route for androstenediol, which by-passes l7a-
hydroxypregnenolone and possibly also pregnenolone. Because 
of the limited number of perfusion experiments in which 
androstenediol has been measured, these results need veri-
fication before further conclusions are drawn. Furthermore, 
the method used is an indirect method for demonstrating the 
existence of precursors other than pregnenolone and the 
second direct precursor of androstenediol should be found. 
Nevertheless, this result gave rise to some speculation. 
If cholesterol hydroperoxide is involved in the side-chain 
. 69 70 
cleavage react~on ' , unexpected rearrangements may result 
in a direct degration of cholesterol to androstenediol, 
although the formation of a c 8-fragment during the choleste-
rol side-chain cleavage reaction has never been shown to 
13 
occur 
An isotope effect of the tritium on reaction rates is 
possible during steroid metabolism71 , but can be excluded 
3 for the metabolism of 16- H-pregnenolone, because the per-
fusion experiments with 16- 3H- and 4- 14c-pregnenolone demon-
strated a constant 3H; 14c ratio in the products. 
Steroid sulfates as possible precursors 
Precursor steroids14 ' 65 in the peripheral blood can, 
when present, be converted to testosterone in the testis. 
Peripheral blood plasma of rabbits was shown to contain 
some androstenediol monosulfate (1.6 nmoles/100 ml), 
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although only minute quantities of free steroids were found 
(see paragraph 2.3.5). As demonstrated, rabbit testes con-
tain steroid sulfatase activity. However, steroid sulfates 
penetrate only slowly into intact cells72 and the quantity 
of androstenediol monosulfate which passes through the tes-
tis (about 0.3 nmoles/30 min) is insufficient to serve as a 
quantitatively important source for the androstenediol. 
Rabbit testes, at least unstimulated testes, virtually 
lack the presence of androstenediol sulfate and dehydro-
epiandrosterone sulfate and therefore steroid biosynthesis 
via the b5 ,3s-hydroxysteroid sulfate pathway is insignifi-
cant. In this respect there is a marked difference with the 
human testis, which contains much higher levels of 6 5 ,3s-
5 hydroxysteroid sulfates than the free 6 ,3S-hydroxy-
steroids17. More recent evidence indicates, however, that 
steroid sulfates are preferentially synthesized from the 
corresponding free steroids 73 , 74 and can merely be regarded 
as side-products of androgen biosynthesis. 
It is concluded that during perfusion of rabbit testis 
with HCG: 
the major part of testosterone was synthesized via the 
6 5 ,3S-hydroxysteroid pathway and androstenediol. 
- dehydroepiandrosterone was almost exclusively derived 
from 17a-hydroxypregnenolone. 
- the ratio of specific activities of androstenediol to 
dehydroepiandrosterone was 0.6 and this may indicate the 
presence of an unknown source of androstenediol. Andros-
tenediol sulfate did not contribute significantly to 
testosterone biosynthesis. 
128 
2.5 References 
1 Nakano,H., Sato,H. and Tamaoki,B. (!968)Steroids ~,291-298 
2 Nakano,H. and Tarnaoki,B. (1969)Arch.Biochern.Biophys. 129, 
771-773 
3 Matsumoto,K. and Samuels,L.T. (1969)Endocrinology 85,402-409 
4 Milewich,L. and Axelrod,L.R. (1972)Arch.Biochem.Biophys. 
153,188-192 
5 Burstein,S. and Dorfman,R.I. (1962)Acta Endocrine!. iQ,lSB-202 
6 Gual,C., Lemus,A.E., Kline,I.T., Gut,M. and Dorfman,R.I. 
(1962)J.Clin.Endocrinol.Metab. ~,1193-1195 
7 Jungmann,R.A. (1968)Biochim.Biophys.Acta !£!,110-123 
8 Jungmann,R.A. (1968)Steroids _!l,205-214 
9 Burstein,S., zeemoscianyk,H., Co,N., Adelson,M., Prasad,D.S.M., 
Greenberg,A. and Gut,M. (l97l)Biochim.Biophys.Acta 231,223-232 
10 Hochberg,R.B., Mickan,H. and Lieberman,S. (1971)Biochim. 
Biophys.Acta 231,208-222 
11 Shimuzu,K. (1966)in "Dynamics of Steroid Hormones"(Pincus,G., 
Nakano,T. and Tait,J.F.,eds) ,pp.481-492,Academic Press,New 
York 
12 Burstein,S., Kimball,H.L., Chaudhuri,N.K. and Gut,M. (1968) 
J.Biol.Chem. ~,4417-4425 
13 Burstein,S. and Gut,M. (1971)Rec.Progr.Hormone Res. 27,303-344 
14 Baird,D., Horton,R., Longcope,C. and Tait,J.F. (1968) 
Perspect.Biol.Med. 1,384-395 
15 Wang,D.Y. and Bulbrook,R.D. (1968)Advan.Reprod.Physiol. l• 
113-146 
16 Telegdy,G., ~reeks,J.W., Archer,D.F., Wiqvist,N. and 
Diczfalusy,E. (1970)Acta Endocrine!. .§.1,119-133 
17 Ruokonen,A., Laatikainen,T., Laitinen,E.A. and Vihko,R. 
(1972)Biochemistry !!,1411-1416 
18 Laatikainen,T., Laitinen,E.A. and Vihko,R. (1971) 
J.Clin.Endocrinol.Metab. 29,219-224 
19 Laatikainen,T., Laitinen,E.A. and Vihko,R. (1971) 
J.Clin.Endocrinol.Metab. 32,59-64 
129 
20 Payne,A.H. (l97l)Biochirn.Biophys.Acta 258,473-483 
21 Payne,A.H., Jaffe,R.B. and Abell,M.R. (1971) 
J.Clin.Endocrinol.Metab. l},582-591 
22 Payne,A.H. and Mason,M. (1965)Stero1ds 6,323-337 
23 Payne,A.H. and Jaffe,R.B. (1970)Endocrinology ~,316-322 
24 Payne,A.H., Mason,M. and Jaffe,R.B. (1969)Steroids !!• 
685-703 
25 Notation,A.D. and Ungar,F. {1969)Steroids l!,151-159 
26 Notation,A.D. and Ungar,F. {1969)Biochemistry ~,501-506 
27 Notation,A.D. and Ungar,F. (1972)Endocrinology 2Q,1537-1542 
28 Aakvaag,A., Hagen,A.A. and Eik-Nes,K.B. (1964)Biochim. 
Biophys.Acta 86,622-627 
29 Oertel,G.W., Wendlberger,F., Menzel,P., Treiber,L. and 
Knapstein,P. (1967)Eur.J.Steroids ~,299-316 
30 Raheja,M.C. and Lucis,O.J. (1970)J.Endocrinol. !i,21-28 
31 Van der Molen,H.J. and Eik-Nes,K.B. (1971)Biochim.Biophys. 
Acta 248,343-362 
32 Rosner,J.M., Horita,S. and Forsham,P.H. (1964)Endocrinology 
]2_, 299-303 
33 Yanaihara,T. and Troen,P. (1972)J.Clin.Endocrinol. ]i, 
783-792 
34 Rosner,J.M. and Macome,J.c. (1970)Steroids !2,181-194 
35 De Jong,F.H. and van der Holen,H J. (1972)J.Endocrinol . 
.21,461-474 
36 Leymarie,P. and savard,K. (1968)J.Clin.Endocrinol.Metab. 
~. 1547-1554 
37 Aakvaag,A. (1969)Acta Endocrinol. ..§_Q,517-526 
38 MacAulay,M.A. and Weliky,I. (1968)J.Clin.Endocrinol.Metab . 
.?.§_,819-830 
39 Bedrak,E. and Sarnuels,L.T. (1969)Endocrinology §2_,1186-1195 
40 Rosner,J.M. and Macome,J.C. (1970)Steroids !2,181-193 
41 Braunsberg,H. and James,V.H.T. (1967)J.Clin.Endocrinol. 
Metab. 12,1174-1188 
42 Tait,S.A.S., Tait,J.F., Okamoto,M. and Flood,C.(1967) 
Endocrinology il,1213-1225 
43 Bell,J.B.G., Vinson,G.P., Hopkin,O.J. and Lacy,D. (1968) 
Biochim.Biophys.Acta !£i,412-420 
130 
44 Matsumoto,K., Mondy,Y. and Samuels,L.T. (1972)in Abstracts 
of Fourth Int. Congress of Endocrinology, Int.Congress 
Series ~,p.9,Excerpta Medica Foundation,Amsterdam 
45 Deshpande,N., Jensen,v., Carson,P., Bulbrook,R.D. and 
Douss,T.W. (1970)J.Endocrinol. !2,231-242 
46 Yamaji,T., Motohashi,K., Tanioka,T. and Ibayashi,H. (1968) 
Endocrinology ~,992-1000 
47 Vinson,G.P. and Whitehouse,B.J. (1969)Acta Endocrine!. il• 
695-7J8 
48 Vinson,G.P. and Whitehouse,B.J. (1969)Acta Endocrine!. ~, 
709-719 
49 Whitehouse,B.J. and Vinson,G.P. (1971)Acta Endocrine!. ~. 
467-476 
50 Zilversmit,D.B., Entenman,C. and Fishler,M.C. (1943) 
J.Gen.Physiol. ~,325-331 
51 Tait,J.F. and Burstein,S. (1965)in The Hormones(Pincus,G., 
Thimann,K.V. and Astwood,E.B. ,eds) ,Vol.5,chapter 4,Academic 
Press,New York 
52 Zilversmit,D.B. and Wentworth,R.A. (1970)J.Lipid Res. ll• 
551-557 
53 Bergner,P.E. (1964)J.Theoc.Biol. ~,137-138 
54 Gurpide,E. (1969)J.Biol.Chem. ~,5159-5169 
55 Ewing,L.L. and Eik-Nes,K.B. (1966)Can.J.Biochem. !!,1327-1344 
56 VanDemark,N.L. and Ewing,L.L. (1963)J.Reprod.Fert. ~,l-24 
57 Hall,P.F. (1965)Endocrinology ~,396 
58 Waites,G.M.M. and Moule,G.R. (l960)J.Reprod.Fert. !,223-229 
59 Fletscher,G.L., Hardy,D.c. and Idler,D.R. (1969) 
Endocrinology ~,552-560 
60 Burstein,S. and Lieberman,S. (l958)J.Biol.Chem. ~,331-335 
61 Vihko,R. (l966)Acta Endocrine!. Suppl.~,50-64 
62 Pierrepoint,C.G., Galley,J.Mci., Griffiths,K. and Grant,J.K., 
(1967)J.Endocrinol. ~,61 
63 Menini,E. and Norymberski,J.K. (1962)Biochem.J. 84,195-201 
64 Fishman,J. (l966)J.Org.Chem. 2!,520-525 
65 Lipsett,M.B. (1971)in Proc.Third Intern. Congress on Hormonal 
Steroids(James,V.H.T. and Martini,L.,eds) ,pp.8-l3,Excerpta 
Medica,Amsterdam 
66 Eik-Nes,K.B. (1967)J.Reprod.Fert. Suppl.l,125-141 
67 Ewing,L.L. and Eik-Nes,K.B. (l966)Can.J.Biochem. !!,1327-1344 
131 
68 Eik-Nes,K.B. (1971)Rec.Progr.Hormone Res. ll,517-535 
69 Van Lier,J.E. and Smith,L.L. (1970)Biochim.Biophys.Acta 21Q, 
153-163 
70 Lieberman,S., Bandy,L., Lippman,V. and Robert,K.D. (1969) 
Biochem.Biophys.Res.Comm. }i,367-371 
71 Brodie,H.J. and Kim, I. (1972)in Abstracts of Fourth Intern. 
Congress Endocrino1ogy,Washington,Excerpta Medica,Intern. 
Congress Series 256,Abstract 23 
72 Mulder,E., Lamers-Stahlhofen,G.J.M. and Vander Molen,H.J. 
(1972)Biochim.Biophys.Acta 260,290-297 
73 Yanaihara,T. and Troen,P. (1972)J.Clin.Endocrino1. }i 1 793-800 
74 Cooke,B.A., Cowan,R.A. and Taylor,P.D. (1970)J.Endocrinol. 
_±2, 295-307 
75 Cameron,E.H.D. and Griffiths,K. (1968)J.Endocrinol. 11.,327-338 
132 
Summary 
Testosterone formation in the testis is regulated in 
vivo by the hypophysial hormone LH and indirectly by the 
negative feedback effect of androgens on the hypothalamus 
and hypophysis. Several steroids can inhibit the in vitro 
activity of enzymes required for steroidogenesis and it is 
often suggested that inhibition by steroids is of importance 
for the control of steroidogenesis at the cellular level 
in vivo. 
The first part of this thesis describes a study of the 
inhibition of testicular cl7,20-lyase by 17a,20a-dihydroxy-
4-pregnen-3-one, a metabolite of l7a-hydroxyprogesterone. 
The significance of this inhibition was evaluated for the 
testosterone biosynthesis in rat and rabbit testes in vivo. 
The following results were obtained. 
1. Radioactively labelled progesterone and !?a-hydroxy-
progesterone were metabolized to 17a,20a-dihydroxy-4-
pregnen-3-one during incubation and perfusion experiments. 
2. 17a,20a-Dihydroxy-4-pregnen-3-one (Ki = 9 ~M) and 20a-
dihydroprogesterone (Ki = 2-5 ~M) inhibited c 17 , 20-lyase 
activity for the conversion of 17a-hydroxyprogesterone 
(Km = 2 ~M) during incubation of various rat (and rab-
bit) testis preparations. However, infusion of these 
steroids into the arterial blood (10 ~M) during perfu-
sion of rabbit testes did not inhibit c 17 , 20-lyase. 
3. With a newly developed, sensitive method for the estima-
tion of 17a,20a-dihydroxy-4-pregnen-3-one it was not 
possible to conclude if any 17a,20a-dihydroxy-4-pregnen-
3-one was present in rat and rabbit testis tissue and in 
testicular venous blood. If present, the levels of this 
potential inhibitor in testis tissue were at least five 
times lower than the levels of l?a-hydroxyprogesterone, 
the substrate for the c17,20-lyase. 
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4. The 20a-hydroxysteroid dehydrogenase activity of rat 
testis was mainly localized (97%) in the seminiferous 
tubules and not at the site of testosterone formation in 
the interstitial tissue. 
5. It has therefore been concluded that 17a,20a-dihydroxy-
4-pregnen-3-one has no function in the regulation of 
c 17 , 20-lyase activity and testosterone production in the 
testis under physiological conditions. 
6. The c 17 , 20-lyase activity from rat testis can be compe-
titively inhibited by 178-ureido-1,4-androstadien-3-one 
(Ki is approximately 0. 2 ]JM). 
It is generally accepted that steroids are derived 
5 from cholesterol and are formed along the ~ ,3S-hydroxy-
steroid pathway and the ~ 4 ,3-oxosteroid pathway. In the rat 
testis the ~ 4 ,3-oxosteroid pathway is the quantitatively 
important route for testosterone biosynthesis, while both 
pathways are involved in the testes of man, dog and rabbit. 
The role of steroid sulfates in the formation of ~S ,3S-
hydroxysteroids is unclear at present. 
The second part of this thesis deals with the role of 
~ 5 ,3s-hydroxysteroids in testosterone formation. In rabbit 
testis the relative importance of the ~ 4 ,3-oxosteroid 
pathway and the ~ 5 ,36-hydroxysteroid pathway for testoste-
rone production was determined and the existence of precur-
sors of dehydroepiandrosterone and androstenediol other 
than pregnenolone and 17a-hydroxypregnenolone was investi-
gated. For this purpose rabbit testes were perfused in vitro 
with radioactively labelled substrates and the specific 
radioactivities of the formed steroids in testis tissue and 
spermatic venous blood were measured. It was observed that: 
7. alkaline treatment eliminated the tritium label from 
metabolites of 16- 3H-pregnenolone, which contained a 
17-oxogroup. This elimination was prevented by modifica-
tion of the isolation procedure. 
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8. the larger part of the testosterone was synthesized via 
the ~ 5 ,36-hydroxysteroid pathway and was derived from 
androstenediol. 
9. during HCG administration dehydroepiandrosterone in rab-
bit testis was almost exclusively derived from 17a-
hydroxypregnenolone. 
10. after perfusion of l6- 3H-pregnenolone the ratio of spe-
cific radioactivities of androstenediol to dehydroepian-
drosterone in testicular venous blood was 0.6, which 
might reflect the presence of an unknown source of an-
drostenediol. It is unlikely that androstenediol mono-
sulfate contributed significantly to testosterone bio-
synthesis. 
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Samenvatting 
De biosynthese van het horrnoon testosteron in de tes-
tis wordt in vivo gereguleerd door het hypofysaire horrnoon 
LH, terwijl testosteron in de perifere circulatie de sekre-
tie van LH kan belnvloeden. Onder in vitro kondities kunnen 
diverse steroiden een remmende invloed uitoefenen op de ak-
tiviteit van enzymen, betrokken bij de steroid biosynthese. 
Het is niet bekend of dergelijke mogelijkheden voor inhibi-
tie van belang zijn voor de regulatie van deze steroid bio-
synthese onder in vivo ornstandigheden. In dit verband werd 
de rernming van het enzyrn c 17 , 20-lyase bestudeerd. 
In het eerste deel van dit proefschrift wordt een on-
derzoek beschreven over de remming van c17 , 20-lyase aktivi-
teit door 17a,20a-dihydroxy-4-pregneen-3-on (17,20-0H-P) in 
de testis. Het enzyrn 20a-hydroxysteroid dehydrogenase,dat 
nodig is voor de vorrning van 17,20-0H-P uit 17a-hydroxy-
progesteron, is aanwezig in testis en daarom is onderzocht 
of een mogelijke remming van de c 17 , 20-lyase aktiviteit van 
belang is voor de regulatie van de testosteron synthese in 
de testes van ratten en konijnen in vivo. De resultaten 
kunnen als volgt worden samengevat: 
1. Radioaktief gemerkt progesteron en 17a-hydroxyprogeste-
ron worden tijdens inkubatie-en perfusie-experirnenten 
orngezet in ondermeer 17a,20a-dihydroxy-4-pregneen-3-on. 
2. 17a,20a-Dihydroxy-4-pregneen-3-on (Ki = 9 ~M) en 2Qa-
dihydroprogesteron (Ki = 2-5 ~M) remmen de c 17 , 20-lyase 
aktiviteit (Km = 2 vM) in inkubatie-experimenten met 
diverse preparaten van ratte- (en konijne-)testis. Er 
kon geen remming van de c 17 , 20-lyase aktiviteit aange-
toond worden, indien deze verbindingen tijdens perfusie-
proeven van konijnetestes Werden toegevoegd aan het 
arteriele bloed (10 ~M). 
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3. Er werd een methode ontwikkeld om kleine hoeveelheden 
17a,20a-dihydroxy-4-pregneen-3-on te meten. Echter, de 
aanwezigheid van deze potentiele remmer in testis van 
ratten en konijnen en in testikulair veneus bloed kon 
niet met zekerheid aangetoond worden. Indien 17a,20a-di-
hydroxy-4-pregneen-3-on in testisweefsel aanwezig is, 
dan is de ~oncentratie tenminste vijfmaal lager dan die 
van 17a-hydroxyprogesteron. 
4. De 20a-hydroxysteroid dehydrogenase aktiviteit in ratte-
testis is hoofdzakelijk (97% van de aktiviteit in tes-
tis) aanwezig in de seminifere tubuli en niet in het 
interstitiele weefsel, waar het testosteron geproduceerd 
wordt. 
5. Uit bovenstaande resultaten werd de konklusie getrokken 
dat onder fysiologische omstandigheden 17a,20a-dihydroxy-
4-pregneen-3-on geen funktie kan vervullen bij de regu-
latie van de testosteron produktie in de testis. 
6. De c 17 , 20-lyase uit rattetestis wordt kompetitief geremd 
door l?s-ureido-1,4-androstadieen-3-on (Ki is ongeveer 
2 •M). 
Er wordt algemeen aangenomen dat testosteron gevormd 
kan worden uit cholesterol via de 6 4 ,3-oxosteroid route en 
de 65 ,3s-hydroxysteroid route. Beide route 1 s zijn betrokken 
bij de testosteron synthese in de testes van mannen, honden 
en konijnen, terwijl in rattetestis alleen de 6 4 ,3-oxo-
steroid van belang is. Over de rol van steroidsulfaten bij 
de vorrning van 6 5 ,38-hydroxysteroiden bestaat geen duide-
lijke indruk. 
In het tweede deel van dit proefschrift wordt een on-
derzoek beschreven naar de bijdrage van 65 ,38-hydroxy-
steroiden tot de testosteron synthese in konijnetestis. De 
bijdrage via de 65 ,38-hydroxysteroid route is kwantitatief 
bepaald en de rnogelijke aanwezigheid van precursors voor 
dehydroepiandrosteron en androsteendiol naast pregnenolon 
en 17a-hydroxypregnenolon is onderzocht. Konijnetestes wer-
den geperfuseerd met radioaktief gernerkte substraten en de 
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specifieke radioaktiviteit van de gevormde steroiden werd 
bepaald. De resultaten zijn als volgt samengevat: 
3 7. Metabolieten van 16- H-pregnenolon met een 17-oxogroep 
verliezen de tritium in alkalisch milieu. De methoden 
voor de isolatie en de bepaling van steroiden werden 
daarom gewijzigd. 
8. Het kwantitatief belangrijkste gedeelte van het testos-
teron werd gesynthetiseerd via de 65 ,3S-hydroxysteroid 
route en werd rechtstreeks gevormd uit androsteendiol. 
Onder invloed van HCG vormde deze bijdrage 97% van het 
totaal gevormde testosteron. 
9. Tijdens HCG toediening werd praktisch alle dehydroepian-
drosteron in konijnetestis gevormd uit 17a-hydroxypreg-
nenolon. 
10. Na perfusie met 16- 3H-pregnenolon was de verhouding van 
de specifieke radioaktiviteit van androsteendiol en 
dehydroepiandrosteron 0,6. Dit kan wijzen op een onbeken-
de synthese route voor androsteendiol. Het is onwaar-
schijnlijk dat via het androsteendiol rnonosulfaat een 
kwantitatief belangrijke bijdrage tot de testosteron 
produktie wordt geleverd. 
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